TapewireFind a company

organization · Reporting owner

BAUPOST GROUP LLC/MA

Disclosed activity across 6 companies

Tapewire entity
98303
SEC CIK
0001061768

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Translate Bio, Inc.TBIO · Entity 13543910% ownerSeptember 14, 2021September 16, 2021
VIASAT INCVSAT · Entity 174410% ownerJuly 23, 2020July 27, 2020

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Translate Bio, Inc.

Report date September 14, 2021 · Filed September 16, 2021 · Amendment

Jointly reported with Baupost Group GP, L.L.C., KLARMAN SETH A

Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeIndirectSee footnote 1 and 20 Reported balance After 2021-09-14 transaction · row 1 Amendment: may correct only part of an earlier disclosure.
1 source row

Row 1 · 2021-09-14 · Other · Disposed 18,044,239 · Balance 0

F3: On September 14, 2021, the Agreement and Plan of Merger among Sanofi, Vector Merger Sub Inc. and Translate Bio Inc. ("Merger Agreement") was consummated and Sanofi completed its acquisition of the Issuer as described in the 8-K filed by the Issuer on September 14, 2021, and incorporated herein by reference. In connection with the consummation of the merger, all shares of Common Stock of the Issuer held by the Reporting Persons were acquired at the tender offer price of $38.00 per share.

F1: This statement on Form 4 is being jointly filed by The Baupost Group, L.L.C. ("Baupost"), Baupost Group GP, L.L.C. ("BG GP") and Seth A. Klarman ("Mr. Klarman") (collectively, the "Reporting Persons"). Baupost is a registered investment adviser. The principal business of Baupost is to act as an investment adviser to various private investment limited partnerships. BG GP, as the manager of Baupost, and Mr. Klarman, as the sole managing member of BG GP and a controlling person of Baupost, may be deemed to have beneficial ownership under Section 13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), of the securities beneficially owned by Baupost. Securities reported on this Form 4 as being beneficially owned by Baupost were purchased on behalf of certain of such partnerships.

F2: (Continued from Footnote 1) The Reporting Persons disclaim beneficial ownership of the securities indicated except to the extent of their pecuniary interest therein, and the reporting herein of such securities shall not be construed as an admission that the Reporting Persons are the beneficial owners thereof for purposes of Section 16 of the Exchange Act or for any other purpose.

Filing footnotes · ownership attribution and instrument terms

F1: This statement on Form 4 is being jointly filed by The Baupost Group, L.L.C. ("Baupost"), Baupost Group GP, L.L.C. ("BG GP") and Seth A. Klarman ("Mr. Klarman") (collectively, the "Reporting Persons"). Baupost is a registered investment adviser. The principal business of Baupost is to act as an investment adviser to various private investment limited partnerships. BG GP, as the manager of Baupost, and Mr. Klarman, as the sole managing member of BG GP and a controlling person of Baupost, may be deemed to have beneficial ownership under Section 13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), of the securities beneficially owned by Baupost. Securities reported on this Form 4 as being beneficially owned by Baupost were purchased on behalf of certain of such partnerships.

F2: (Continued from Footnote 1) The Reporting Persons disclaim beneficial ownership of the securities indicated except to the extent of their pecuniary interest therein, and the reporting herein of such securities shall not be construed as an admission that the Reporting Persons are the beneficial owners thereof for purposes of Section 16 of the Exchange Act or for any other purpose.

F3: On September 14, 2021, the Agreement and Plan of Merger among Sanofi, Vector Merger Sub Inc. and Translate Bio Inc. ("Merger Agreement") was consummated and Sanofi completed its acquisition of the Issuer as described in the 8-K filed by the Issuer on September 14, 2021, and incorporated herein by reference. In connection with the consummation of the merger, all shares of Common Stock of the Issuer held by the Reporting Persons were acquired at the tender offer price of $38.00 per share.

VIASAT INC

Report date July 23, 2020 · Filed July 27, 2020

Jointly reported with KLARMAN SETH A, Baupost Group GP, L.L.C.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeIndirectSee footnote 1.16,288,959 Reported balance After 2020-07-23 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 1 · 2020-07-23 · Purchase · Acquired 2,556,891 · Balance 16,288,959

F1: This statement on Form 4 is being jointly filed by The Baupost Group, L.L.C. ("Baupost"), Baupost Group GP, L.L.C. ("Baupost GP") and Seth A. Klarman ("Mr. Klarman") (collectively, the "Reporting Persons"). Baupost is a registered investment adviser. The principal business of Baupost is to act as an investment adviser to various private investment limited partnerships. Baupost GP, as the manager of Baupost, and Mr. Klarman, as the sole managing member of Baupost GP and a controlling person of Baupost, may be deemed to have beneficial ownership under Section 13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), of the securities beneficially owned by Baupost. Securities reported on this Form 4 as being beneficially owned by Baupost were purchased on behalf of certain of such partnerships.

F2: (Continued from footnote 1) The Reporting Persons disclaim beneficial ownership of the securities indicated except to the extent of their pecuniary therein, and the reporting herein of such securities shall not be construed as an admission that the Reporting Persons are the beneficial owners thereof for purpose of Section 16 or for any other purpose.

Filing footnotes · ownership attribution and instrument terms

F1: This statement on Form 4 is being jointly filed by The Baupost Group, L.L.C. ("Baupost"), Baupost Group GP, L.L.C. ("Baupost GP") and Seth A. Klarman ("Mr. Klarman") (collectively, the "Reporting Persons"). Baupost is a registered investment adviser. The principal business of Baupost is to act as an investment adviser to various private investment limited partnerships. Baupost GP, as the manager of Baupost, and Mr. Klarman, as the sole managing member of Baupost GP and a controlling person of Baupost, may be deemed to have beneficial ownership under Section 13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), of the securities beneficially owned by Baupost. Securities reported on this Form 4 as being beneficially owned by Baupost were purchased on behalf of certain of such partnerships.

F2: (Continued from footnote 1) The Reporting Persons disclaim beneficial ownership of the securities indicated except to the extent of their pecuniary therein, and the reporting herein of such securities shall not be construed as an admission that the Reporting Persons are the beneficial owners thereof for purpose of Section 16 or for any other purpose.

Past disclosures · reporting ended (4)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Garrett Motion Inc.

Report date June 13, 2023 · Filed June 15, 2023

Jointly reported with Baupost Group GP, L.L.C., KLARMAN SETH A

Section 16 reporting ended · disclosed 2023-06-15. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeIndirectSee Footnotes26,570,589 Last balance in matching sequence After 2023-06-15 transaction · row 4 Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
4 source rows

Row 1 · 2023-06-13 · Conversion · Acquired 25,462,810 · Balance 31,195,589

F3: The common stock reported herein were issued following the automatic conversion of all outstanding the Series A Cumulative Convertible Preferred Stock of Garrett Motion Inc. (the "Conversion") in accordance with the Issuer's certificate of designations for the Series A Cumulative Convertible Preferred Stock.

F1: This statement on Form 4 is being jointly filed by The Baupost Group, L.L.C. ("Baupost"), Baupost Group GP, L.L.C. ("Baupost GP"), and Seth A. Klarman ("Mr. Klarman") (collectively, the "Reporting Persons"). Baupost is a registered investment adviser. The principal business of Baupost is to act as an investment adviser to various private investment limited partnerships. Baupost GP, as the manager of Baupost, and Mr. Klarman, as the sole managing member of Baupost GP and a controlling person of Baupost, may be deemed to have beneficial ownership under Section 13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), of the securities beneficially owned by Baupost. Securities reported on this Form 4 as being beneficially owned by Baupost were purchased on behalf of certain of such partnerships.

F2: (Continued from footnote 1) The Reporting Persons disclaim beneficial ownership of the securities indicated except to the extent of their pecuniary interest therein, and the reporting herein of such securities shall not be construed as an admission that the Reporting Persons are the beneficial owners thereof for purposes of Section 16 of the Exchange Act or for any other purpose.

Row 2 · 2023-06-13 · Sale · Disposed 500,000 · Balance 30,695,589

F1: This statement on Form 4 is being jointly filed by The Baupost Group, L.L.C. ("Baupost"), Baupost Group GP, L.L.C. ("Baupost GP"), and Seth A. Klarman ("Mr. Klarman") (collectively, the "Reporting Persons"). Baupost is a registered investment adviser. The principal business of Baupost is to act as an investment adviser to various private investment limited partnerships. Baupost GP, as the manager of Baupost, and Mr. Klarman, as the sole managing member of Baupost GP and a controlling person of Baupost, may be deemed to have beneficial ownership under Section 13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), of the securities beneficially owned by Baupost. Securities reported on this Form 4 as being beneficially owned by Baupost were purchased on behalf of certain of such partnerships.

F2: (Continued from footnote 1) The Reporting Persons disclaim beneficial ownership of the securities indicated except to the extent of their pecuniary interest therein, and the reporting herein of such securities shall not be construed as an admission that the Reporting Persons are the beneficial owners thereof for purposes of Section 16 of the Exchange Act or for any other purpose.

Row 3 · 2023-06-14 · Sale · Disposed 3,100,000 · Balance 27,595,589

F4: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.71 to $7.87. The Reporting Person undertakes to provide the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F1: This statement on Form 4 is being jointly filed by The Baupost Group, L.L.C. ("Baupost"), Baupost Group GP, L.L.C. ("Baupost GP"), and Seth A. Klarman ("Mr. Klarman") (collectively, the "Reporting Persons"). Baupost is a registered investment adviser. The principal business of Baupost is to act as an investment adviser to various private investment limited partnerships. Baupost GP, as the manager of Baupost, and Mr. Klarman, as the sole managing member of Baupost GP and a controlling person of Baupost, may be deemed to have beneficial ownership under Section 13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), of the securities beneficially owned by Baupost. Securities reported on this Form 4 as being beneficially owned by Baupost were purchased on behalf of certain of such partnerships.

F2: (Continued from footnote 1) The Reporting Persons disclaim beneficial ownership of the securities indicated except to the extent of their pecuniary interest therein, and the reporting herein of such securities shall not be construed as an admission that the Reporting Persons are the beneficial owners thereof for purposes of Section 16 of the Exchange Act or for any other purpose.

Row 4 · 2023-06-15 · Sale · Disposed 1,025,000 · Balance 26,570,589

F1: This statement on Form 4 is being jointly filed by The Baupost Group, L.L.C. ("Baupost"), Baupost Group GP, L.L.C. ("Baupost GP"), and Seth A. Klarman ("Mr. Klarman") (collectively, the "Reporting Persons"). Baupost is a registered investment adviser. The principal business of Baupost is to act as an investment adviser to various private investment limited partnerships. Baupost GP, as the manager of Baupost, and Mr. Klarman, as the sole managing member of Baupost GP and a controlling person of Baupost, may be deemed to have beneficial ownership under Section 13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), of the securities beneficially owned by Baupost. Securities reported on this Form 4 as being beneficially owned by Baupost were purchased on behalf of certain of such partnerships.

F2: (Continued from footnote 1) The Reporting Persons disclaim beneficial ownership of the securities indicated except to the extent of their pecuniary interest therein, and the reporting herein of such securities shall not be construed as an admission that the Reporting Persons are the beneficial owners thereof for purposes of Section 16 of the Exchange Act or for any other purpose.

Series A Cumulative Convertible Preferred StockSEC Table II · derivative / convertible securityIndirectSee Footnotes0 Reported balance After 2023-06-13 transaction · row 5 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 5 · 2023-06-13 · Conversion · Acquired 25,462,810 · Balance 0

F3: The common stock reported herein were issued following the automatic conversion of all outstanding the Series A Cumulative Convertible Preferred Stock of Garrett Motion Inc. (the "Conversion") in accordance with the Issuer's certificate of designations for the Series A Cumulative Convertible Preferred Stock.

F1: This statement on Form 4 is being jointly filed by The Baupost Group, L.L.C. ("Baupost"), Baupost Group GP, L.L.C. ("Baupost GP"), and Seth A. Klarman ("Mr. Klarman") (collectively, the "Reporting Persons"). Baupost is a registered investment adviser. The principal business of Baupost is to act as an investment adviser to various private investment limited partnerships. Baupost GP, as the manager of Baupost, and Mr. Klarman, as the sole managing member of Baupost GP and a controlling person of Baupost, may be deemed to have beneficial ownership under Section 13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), of the securities beneficially owned by Baupost. Securities reported on this Form 4 as being beneficially owned by Baupost were purchased on behalf of certain of such partnerships.

F2: (Continued from footnote 1) The Reporting Persons disclaim beneficial ownership of the securities indicated except to the extent of their pecuniary interest therein, and the reporting herein of such securities shall not be construed as an admission that the Reporting Persons are the beneficial owners thereof for purposes of Section 16 of the Exchange Act or for any other purpose.

Filing footnotes · ownership attribution and instrument terms

F1: This statement on Form 4 is being jointly filed by The Baupost Group, L.L.C. ("Baupost"), Baupost Group GP, L.L.C. ("Baupost GP"), and Seth A. Klarman ("Mr. Klarman") (collectively, the "Reporting Persons"). Baupost is a registered investment adviser. The principal business of Baupost is to act as an investment adviser to various private investment limited partnerships. Baupost GP, as the manager of Baupost, and Mr. Klarman, as the sole managing member of Baupost GP and a controlling person of Baupost, may be deemed to have beneficial ownership under Section 13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), of the securities beneficially owned by Baupost. Securities reported on this Form 4 as being beneficially owned by Baupost were purchased on behalf of certain of such partnerships.

F2: (Continued from footnote 1) The Reporting Persons disclaim beneficial ownership of the securities indicated except to the extent of their pecuniary interest therein, and the reporting herein of such securities shall not be construed as an admission that the Reporting Persons are the beneficial owners thereof for purposes of Section 16 of the Exchange Act or for any other purpose.

F3: The common stock reported herein were issued following the automatic conversion of all outstanding the Series A Cumulative Convertible Preferred Stock of Garrett Motion Inc. (the "Conversion") in accordance with the Issuer's certificate of designations for the Series A Cumulative Convertible Preferred Stock.

F4: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.71 to $7.87. The Reporting Person undertakes to provide the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

KERYX BIOPHARMACEUTICALS INC

Report date December 11, 2018 · Filed December 13, 2018

Jointly reported with Baupost Group GP, L.L.C., KLARMAN SETH A

Section 16 reporting ended · disclosed 2018-12-13. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeIndirectSee footnote 1 and 20 Last balance in matching sequence After 2018-12-12 transaction · row 3 Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
3 source rows

Row 1 · 2018-12-11 · Grant · Acquired 35,582,335 · Balance 61,374,013

F1: This statement on Form 4 is being jointly filed by The Baupost Group, L.L.C. ("Baupost"), Baupost Group GP, LLC ("Baupost GP") and Seth A. Klarman ("Mr. Klarman") (collectively, the "Reporting Persons"). Baupost is a registered investment adviser. The principal business of Baupost is to act as an investment adviser to various private investment limited partnerships. Baupost GP, as the manager of Baupost, and Mr. Klarman, as the sole managing member of Baupost GP and a controlling person of Baupost, may be deemed to have beneficial ownership under Section 13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), of the securities beneficially owned by Baupost. Securities reported on this Form 4 as being beneficially owned by Baupost were purchased on behalf of certain of such partnerships.

F2: (Continued from footnote 1) The Reporting Persons disclaim beneficial ownership of the securities indicated except to the extent of their pecuniary interest therein, and the reporting herein of such securities shall not be construed as an admission that the Reporting Persons are the beneficial owners thereof for purposes of Section 16 of the Exchange Act or for any other purpose.

Row 2 · 2018-12-11 · Grant · Acquired 4,000,000 · Balance 65,374,013

F3: Pursuant to the terms of the Notes Conversion Agreement, dated as of June 28, 2018, by and among Keryx Biopharmaceuticals, Inc., Baupost Group Securities, L.L.C. and, with respect to certain sections only, Akebia Therapeutics, Inc., Baupost Group Securities, L.L.C. agreed to convert its Zero Coupon Senior Convertible Notes due 2021 pursuant to the terms of the governing indenture in exchange for, among other things, the receipt of 4,000,000 share of Common Stock.

F1: This statement on Form 4 is being jointly filed by The Baupost Group, L.L.C. ("Baupost"), Baupost Group GP, LLC ("Baupost GP") and Seth A. Klarman ("Mr. Klarman") (collectively, the "Reporting Persons"). Baupost is a registered investment adviser. The principal business of Baupost is to act as an investment adviser to various private investment limited partnerships. Baupost GP, as the manager of Baupost, and Mr. Klarman, as the sole managing member of Baupost GP and a controlling person of Baupost, may be deemed to have beneficial ownership under Section 13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), of the securities beneficially owned by Baupost. Securities reported on this Form 4 as being beneficially owned by Baupost were purchased on behalf of certain of such partnerships.

F2: (Continued from footnote 1) The Reporting Persons disclaim beneficial ownership of the securities indicated except to the extent of their pecuniary interest therein, and the reporting herein of such securities shall not be construed as an admission that the Reporting Persons are the beneficial owners thereof for purposes of Section 16 of the Exchange Act or for any other purpose.

Row 3 · 2018-12-12 · Disposition to issuer · Disposed 65,374,013 · Balance 0

F4: Pursuant to the terms of the Merger Agreement, dated as of June 28, 2018, by and among Keryx Biopharmaceuticals, Inc., Akebia Therapeutics, Inc. and Alpha Therapeutics Merger Sub Inc., upon the closing of the Merger specified therein, all shares of Common Stock held by the Reporting Persons (including all shares of Common Stock issued pursuant to the terms of the Notes Conversion Agreement) converted into common stock, par value $0.00001 per share, of Akebia Therapeutics, Inc.

F1: This statement on Form 4 is being jointly filed by The Baupost Group, L.L.C. ("Baupost"), Baupost Group GP, LLC ("Baupost GP") and Seth A. Klarman ("Mr. Klarman") (collectively, the "Reporting Persons"). Baupost is a registered investment adviser. The principal business of Baupost is to act as an investment adviser to various private investment limited partnerships. Baupost GP, as the manager of Baupost, and Mr. Klarman, as the sole managing member of Baupost GP and a controlling person of Baupost, may be deemed to have beneficial ownership under Section 13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), of the securities beneficially owned by Baupost. Securities reported on this Form 4 as being beneficially owned by Baupost were purchased on behalf of certain of such partnerships.

F2: (Continued from footnote 1) The Reporting Persons disclaim beneficial ownership of the securities indicated except to the extent of their pecuniary interest therein, and the reporting herein of such securities shall not be construed as an admission that the Reporting Persons are the beneficial owners thereof for purposes of Section 16 of the Exchange Act or for any other purpose.

Zero Coupon Senior Convertible Notes due 2021SEC Table II · derivative / convertible security · Conversion / exercise price $4.63 · Expires 2021-10-15IndirectSee footnote 1 and 20 Reported balance After 2018-12-11 transaction · row 4 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 4 · 2018-12-11 · Exercise / conversion · Disposed Not disclosed · Balance 0

F3: Pursuant to the terms of the Notes Conversion Agreement, dated as of June 28, 2018, by and among Keryx Biopharmaceuticals, Inc., Baupost Group Securities, L.L.C. and, with respect to certain sections only, Akebia Therapeutics, Inc., Baupost Group Securities, L.L.C. agreed to convert its Zero Coupon Senior Convertible Notes due 2021 pursuant to the terms of the governing indenture in exchange for, among other things, the receipt of 4,000,000 share of Common Stock.

F1: This statement on Form 4 is being jointly filed by The Baupost Group, L.L.C. ("Baupost"), Baupost Group GP, LLC ("Baupost GP") and Seth A. Klarman ("Mr. Klarman") (collectively, the "Reporting Persons"). Baupost is a registered investment adviser. The principal business of Baupost is to act as an investment adviser to various private investment limited partnerships. Baupost GP, as the manager of Baupost, and Mr. Klarman, as the sole managing member of Baupost GP and a controlling person of Baupost, may be deemed to have beneficial ownership under Section 13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), of the securities beneficially owned by Baupost. Securities reported on this Form 4 as being beneficially owned by Baupost were purchased on behalf of certain of such partnerships.

F2: (Continued from footnote 1) The Reporting Persons disclaim beneficial ownership of the securities indicated except to the extent of their pecuniary interest therein, and the reporting herein of such securities shall not be construed as an admission that the Reporting Persons are the beneficial owners thereof for purposes of Section 16 of the Exchange Act or for any other purpose.

Filing footnotes · ownership attribution and instrument terms

F1: This statement on Form 4 is being jointly filed by The Baupost Group, L.L.C. ("Baupost"), Baupost Group GP, LLC ("Baupost GP") and Seth A. Klarman ("Mr. Klarman") (collectively, the "Reporting Persons"). Baupost is a registered investment adviser. The principal business of Baupost is to act as an investment adviser to various private investment limited partnerships. Baupost GP, as the manager of Baupost, and Mr. Klarman, as the sole managing member of Baupost GP and a controlling person of Baupost, may be deemed to have beneficial ownership under Section 13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), of the securities beneficially owned by Baupost. Securities reported on this Form 4 as being beneficially owned by Baupost were purchased on behalf of certain of such partnerships.

F2: (Continued from footnote 1) The Reporting Persons disclaim beneficial ownership of the securities indicated except to the extent of their pecuniary interest therein, and the reporting herein of such securities shall not be construed as an admission that the Reporting Persons are the beneficial owners thereof for purposes of Section 16 of the Exchange Act or for any other purpose.

F3: Pursuant to the terms of the Notes Conversion Agreement, dated as of June 28, 2018, by and among Keryx Biopharmaceuticals, Inc., Baupost Group Securities, L.L.C. and, with respect to certain sections only, Akebia Therapeutics, Inc., Baupost Group Securities, L.L.C. agreed to convert its Zero Coupon Senior Convertible Notes due 2021 pursuant to the terms of the governing indenture in exchange for, among other things, the receipt of 4,000,000 share of Common Stock.

F4: Pursuant to the terms of the Merger Agreement, dated as of June 28, 2018, by and among Keryx Biopharmaceuticals, Inc., Akebia Therapeutics, Inc. and Alpha Therapeutics Merger Sub Inc., upon the closing of the Merger specified therein, all shares of Common Stock held by the Reporting Persons (including all shares of Common Stock issued pursuant to the terms of the Notes Conversion Agreement) converted into common stock, par value $0.00001 per share, of Akebia Therapeutics, Inc.

Orexigen Therapeutics, Inc.

Report date May 31, 2019 · Filed June 04, 2019

Jointly reported with Baupost Group GP, L.L.C., KLARMAN SETH A

Section 16 reporting ended · disclosed 2019-06-04. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
0% Senior Secured Convertible Notes due 2020SEC Table II · derivative / convertible security · Conversion / exercise price $7.50 · Expires 2020-06-29IndirectSee footnote0 Reported balance After 2019-05-31 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2019-05-31 · Other · Disposed Not disclosed · Balance 0

F3: Such aggregate principal amount of the 0% Senior Secured Convertible Notes due 2020 ("Notes") were converted into post-petition secured obligations under a debtor-in-possession credit facility entered into on March 12, 2018 and approved by the United States Bankruptcy Court for the District of Delaware (the "Bankruptcy Court") on April 13, 2018. At such time 7,802,197 shares of Common Stock were underlying the remaining outstanding aggregate principal amount of the Notes. On May 31, 2019, the Issuer's Modified Amended Plan of Liquidation (the "Plan of Liquidation"), which was confirmed by the Bankruptcy Court on May 17, 2019, became effective. As provided by the Plan of Liquidation, the Reporting Persons surrendered the Notes in exchange for a pro rata distribution of the Issuer's distributable cash, cash proceeds from tax refunds and unused amounts of wind down reserves, each as defined in the Plan of Liquidation.

F4: (Continued from footnote 3)The Plan of Liquidation also provided that all outstanding equity interests would be cancelled for no consideration on the effective date.

F1: This statement on Form 4 is being jointly filed by The Baupost Group, L.L.C. ("Baupost"), Baupost Group GP, L.L.C. ("BG GP"), and Seth A. Klarman (collectively, the "Reporting Persons"). Baupost is a registered investment adviser and acts as an investment adviser to various private investment limited partnerships. BG GP, as the Manager of Baupost, and Seth A. Klarman, as the Managing Member of BG GP and a controlling person of Baupost, may be deemed to have beneficial ownership under Section 13 of the Securities Exchange Act of 1934, as amended, of the securities beneficially owned by Baupost. Securities reported on this Form 4 as being beneficially owned by Baupost were purchased on behalf of certain of such partnerships.

F2: (Continued from footnote 1) The Reporting Persons disclaim beneficial ownership of the securities indicated except to the extent of their pecuniary therein, and the reporting herein of such securities shall not be construed as an admission that the Reporting Persons are the beneficial owners thereof for purpose of Section 16 or for any other purpose.

Warrant Expiring 2020SEC Table II · derivative / convertible security · Conversion / exercise price $60.00 · Expires 2020-09-10IndirectSee footnote0 Reported balance After 2019-05-31 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2019-05-31 · Other · Disposed 5,000,000 · Balance 0

F3: Such aggregate principal amount of the 0% Senior Secured Convertible Notes due 2020 ("Notes") were converted into post-petition secured obligations under a debtor-in-possession credit facility entered into on March 12, 2018 and approved by the United States Bankruptcy Court for the District of Delaware (the "Bankruptcy Court") on April 13, 2018. At such time 7,802,197 shares of Common Stock were underlying the remaining outstanding aggregate principal amount of the Notes. On May 31, 2019, the Issuer's Modified Amended Plan of Liquidation (the "Plan of Liquidation"), which was confirmed by the Bankruptcy Court on May 17, 2019, became effective. As provided by the Plan of Liquidation, the Reporting Persons surrendered the Notes in exchange for a pro rata distribution of the Issuer's distributable cash, cash proceeds from tax refunds and unused amounts of wind down reserves, each as defined in the Plan of Liquidation.

F4: (Continued from footnote 3)The Plan of Liquidation also provided that all outstanding equity interests would be cancelled for no consideration on the effective date.

F1: This statement on Form 4 is being jointly filed by The Baupost Group, L.L.C. ("Baupost"), Baupost Group GP, L.L.C. ("BG GP"), and Seth A. Klarman (collectively, the "Reporting Persons"). Baupost is a registered investment adviser and acts as an investment adviser to various private investment limited partnerships. BG GP, as the Manager of Baupost, and Seth A. Klarman, as the Managing Member of BG GP and a controlling person of Baupost, may be deemed to have beneficial ownership under Section 13 of the Securities Exchange Act of 1934, as amended, of the securities beneficially owned by Baupost. Securities reported on this Form 4 as being beneficially owned by Baupost were purchased on behalf of certain of such partnerships.

F2: (Continued from footnote 1) The Reporting Persons disclaim beneficial ownership of the securities indicated except to the extent of their pecuniary therein, and the reporting herein of such securities shall not be construed as an admission that the Reporting Persons are the beneficial owners thereof for purpose of Section 16 or for any other purpose.

Warrant Expiring 2026SEC Table II · derivative / convertible security · Conversion / exercise price $15.00 · Expires 2026-09-21IndirectSee footnote0 Reported balance After 2019-05-31 transaction · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · 2019-05-31 · Other · Disposed 100,000,000 · Balance 0

F3: Such aggregate principal amount of the 0% Senior Secured Convertible Notes due 2020 ("Notes") were converted into post-petition secured obligations under a debtor-in-possession credit facility entered into on March 12, 2018 and approved by the United States Bankruptcy Court for the District of Delaware (the "Bankruptcy Court") on April 13, 2018. At such time 7,802,197 shares of Common Stock were underlying the remaining outstanding aggregate principal amount of the Notes. On May 31, 2019, the Issuer's Modified Amended Plan of Liquidation (the "Plan of Liquidation"), which was confirmed by the Bankruptcy Court on May 17, 2019, became effective. As provided by the Plan of Liquidation, the Reporting Persons surrendered the Notes in exchange for a pro rata distribution of the Issuer's distributable cash, cash proceeds from tax refunds and unused amounts of wind down reserves, each as defined in the Plan of Liquidation.

F4: (Continued from footnote 3)The Plan of Liquidation also provided that all outstanding equity interests would be cancelled for no consideration on the effective date.

F1: This statement on Form 4 is being jointly filed by The Baupost Group, L.L.C. ("Baupost"), Baupost Group GP, L.L.C. ("BG GP"), and Seth A. Klarman (collectively, the "Reporting Persons"). Baupost is a registered investment adviser and acts as an investment adviser to various private investment limited partnerships. BG GP, as the Manager of Baupost, and Seth A. Klarman, as the Managing Member of BG GP and a controlling person of Baupost, may be deemed to have beneficial ownership under Section 13 of the Securities Exchange Act of 1934, as amended, of the securities beneficially owned by Baupost. Securities reported on this Form 4 as being beneficially owned by Baupost were purchased on behalf of certain of such partnerships.

F2: (Continued from footnote 1) The Reporting Persons disclaim beneficial ownership of the securities indicated except to the extent of their pecuniary therein, and the reporting herein of such securities shall not be construed as an admission that the Reporting Persons are the beneficial owners thereof for purpose of Section 16 or for any other purpose.

Filing footnotes · ownership attribution and instrument terms

F1: This statement on Form 4 is being jointly filed by The Baupost Group, L.L.C. ("Baupost"), Baupost Group GP, L.L.C. ("BG GP"), and Seth A. Klarman (collectively, the "Reporting Persons"). Baupost is a registered investment adviser and acts as an investment adviser to various private investment limited partnerships. BG GP, as the Manager of Baupost, and Seth A. Klarman, as the Managing Member of BG GP and a controlling person of Baupost, may be deemed to have beneficial ownership under Section 13 of the Securities Exchange Act of 1934, as amended, of the securities beneficially owned by Baupost. Securities reported on this Form 4 as being beneficially owned by Baupost were purchased on behalf of certain of such partnerships.

F2: (Continued from footnote 1) The Reporting Persons disclaim beneficial ownership of the securities indicated except to the extent of their pecuniary therein, and the reporting herein of such securities shall not be construed as an admission that the Reporting Persons are the beneficial owners thereof for purpose of Section 16 or for any other purpose.

F3: Such aggregate principal amount of the 0% Senior Secured Convertible Notes due 2020 ("Notes") were converted into post-petition secured obligations under a debtor-in-possession credit facility entered into on March 12, 2018 and approved by the United States Bankruptcy Court for the District of Delaware (the "Bankruptcy Court") on April 13, 2018. At such time 7,802,197 shares of Common Stock were underlying the remaining outstanding aggregate principal amount of the Notes. On May 31, 2019, the Issuer's Modified Amended Plan of Liquidation (the "Plan of Liquidation"), which was confirmed by the Bankruptcy Court on May 17, 2019, became effective. As provided by the Plan of Liquidation, the Reporting Persons surrendered the Notes in exchange for a pro rata distribution of the Issuer's distributable cash, cash proceeds from tax refunds and unused amounts of wind down reserves, each as defined in the Plan of Liquidation.

F4: (Continued from footnote 3)The Plan of Liquidation also provided that all outstanding equity interests would be cancelled for no consideration on the effective date.

Veritiv Corp

Report date November 30, 2023 · Filed December 06, 2023

Jointly reported with Baupost Group GP, L.L.C., KLARMAN SETH A

Section 16 reporting ended · disclosed 2023-12-06. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeIndirectSee Footnote 1 and 20 Reported balance After 2023-11-30 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 1 · 2023-11-30 · Other · Disposed 3,324,324 · Balance 0

F3: On November 30, 2023, the Agreement and Plan of Merger among Verde Purchaser, Verde Merger Sub Inc. and Veritiv Corp ("Merger Agreement") was consummated and Verde Purchaser completed its acquisition of the Issuer as described in the 8-K filed by the Issuer on November 30, 2023, and incorporated herein by reference. In connection with the consummation of the merger, all shares of Common Stock of the Issuer held by the Reporting Persons were acquired at the tender offer price of $170.00 per share.

F1: This statement on Form 4 is being jointly filed by The Baupost Group, L.L.C. ("Baupost"), Baupost Group GP, L.L.C. ("BG GP") and Seth A. Klarman ("Mr. Klarman") (collectively, the "Reporting Persons"). Baupost is a registered investment adviser. The principal business of Baupost is to act as an investment adviser to various private investment limited partnerships. BG GP, as the manager of Baupost, and Mr. Klarman, as the sole managing member of BG GP and a controlling person of Baupost, may be deemed to have beneficial ownership under Section 13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), of the securities beneficially owned by Baupost. Securities reported on this Form 4 as being beneficially owned by Baupost were purchased on behalf of certain of such partnerships

F2: (Continued from Footnote 1) The Reporting Persons disclaim beneficial ownership of the securities indicated except to the extent of their pecuniary interest therein, and the reporting herein of such securities shall not be construed as an admission that the Reporting Persons are the beneficial owners thereof for purposes of Section 16 of the Exchange Act or for any other purpose.

Filing footnotes · ownership attribution and instrument terms

F1: This statement on Form 4 is being jointly filed by The Baupost Group, L.L.C. ("Baupost"), Baupost Group GP, L.L.C. ("BG GP") and Seth A. Klarman ("Mr. Klarman") (collectively, the "Reporting Persons"). Baupost is a registered investment adviser. The principal business of Baupost is to act as an investment adviser to various private investment limited partnerships. BG GP, as the manager of Baupost, and Mr. Klarman, as the sole managing member of BG GP and a controlling person of Baupost, may be deemed to have beneficial ownership under Section 13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), of the securities beneficially owned by Baupost. Securities reported on this Form 4 as being beneficially owned by Baupost were purchased on behalf of certain of such partnerships

F2: (Continued from Footnote 1) The Reporting Persons disclaim beneficial ownership of the securities indicated except to the extent of their pecuniary interest therein, and the reporting herein of such securities shall not be construed as an admission that the Reporting Persons are the beneficial owners thereof for purposes of Section 16 of the Exchange Act or for any other purpose.

F3: On November 30, 2023, the Agreement and Plan of Merger among Verde Purchaser, Verde Merger Sub Inc. and Veritiv Corp ("Merger Agreement") was consummated and Verde Purchaser completed its acquisition of the Issuer as described in the 8-K filed by the Issuer on November 30, 2023, and incorporated herein by reference. In connection with the consummation of the merger, all shares of Common Stock of the Issuer held by the Reporting Persons were acquired at the tender offer price of $170.00 per share.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
November 30, 2023 Filed Dec 6, 2023 16:50 UTC Veritiv Corp VRTV · Entity 107723 OtherCommon Stock 3,324,324 $170.00 $565,135,080.00
Disclosure

SEC source: 0001140361-23-056518 · form4.xml · nonDerivative · entry 1

BAUPOST GROUP LLC/MA · CIK 0001061768 · 10% owner

Baupost Group GP, L.L.C. · CIK 0001738693 · 10% owner

KLARMAN SETH A · CIK 0000899869 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote 1 and 2

Disclosed balance after: 0

F3 · kind: On November 30, 2023, the Agreement and Plan of Merger among Verde Purchaser, Verde Merger Sub Inc. and Veritiv Corp ("Merger Agreement") was consummated and Verde Purchaser completed its acquisition of the Issuer as described in the 8-K filed by the Issuer on November 30, 2023, and incorporated herein by reference. In connection with the consummation of the merger, all shares of Common Stock of the Issuer held by the Reporting Persons were acquired at the tender offer price of $170.00 per share.

F1 · ownership.nature: This statement on Form 4 is being jointly filed by The Baupost Group, L.L.C. ("Baupost"), Baupost Group GP, L.L.C. ("BG GP") and Seth A. Klarman ("Mr. Klarman") (collectively, the "Reporting Persons"). Baupost is a registered investment adviser. The principal business of Baupost is to act as an investment adviser to various private investment limited partnerships. BG GP, as the manager of Baupost, and Mr. Klarman, as the sole managing member of BG GP and a controlling person of Baupost, may be deemed to have beneficial ownership under Section 13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), of the securities beneficially owned by Baupost. Securities reported on this Form 4 as being beneficially owned by Baupost were purchased on behalf of certain of such partnerships

F2 · ownership.nature: (Continued from Footnote 1) The Reporting Persons disclaim beneficial ownership of the securities indicated except to the extent of their pecuniary interest therein, and the reporting herein of such securities shall not be construed as an admission that the Reporting Persons are the beneficial owners thereof for purposes of Section 16 of the Exchange Act or for any other purpose.

Read SEC document
June 15, 2023 Filed Jun 15, 2023 19:36 UTC Garrett Motion Inc. GTX · Entity 1720 SaleCommon Stock 1,025,000 $7.55 $7,738,750.00
Disclosure

SEC source: 0001140361-23-030150 · form4.xml · nonDerivative · entry 4

BAUPOST GROUP LLC/MA · CIK 0001061768 · 10% owner

Baupost Group GP, L.L.C. · CIK 0001738693 · 10% owner

KLARMAN SETH A · CIK 0000899869 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnotes

Disclosed balance after: 26,570,589

F1 · ownership.nature: This statement on Form 4 is being jointly filed by The Baupost Group, L.L.C. ("Baupost"), Baupost Group GP, L.L.C. ("Baupost GP"), and Seth A. Klarman ("Mr. Klarman") (collectively, the "Reporting Persons"). Baupost is a registered investment adviser. The principal business of Baupost is to act as an investment adviser to various private investment limited partnerships. Baupost GP, as the manager of Baupost, and Mr. Klarman, as the sole managing member of Baupost GP and a controlling person of Baupost, may be deemed to have beneficial ownership under Section 13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), of the securities beneficially owned by Baupost. Securities reported on this Form 4 as being beneficially owned by Baupost were purchased on behalf of certain of such partnerships.

F2 · ownership.nature: (Continued from footnote 1) The Reporting Persons disclaim beneficial ownership of the securities indicated except to the extent of their pecuniary interest therein, and the reporting herein of such securities shall not be construed as an admission that the Reporting Persons are the beneficial owners thereof for purposes of Section 16 of the Exchange Act or for any other purpose.

Read SEC document
June 14, 2023 Filed Jun 15, 2023 19:36 UTC Garrett Motion Inc. GTX · Entity 1720 SaleCommon Stock 3,100,000 $7.73 $23,963,000.00
Disclosure

SEC source: 0001140361-23-030150 · form4.xml · nonDerivative · entry 3

BAUPOST GROUP LLC/MA · CIK 0001061768 · 10% owner

Baupost Group GP, L.L.C. · CIK 0001738693 · 10% owner

KLARMAN SETH A · CIK 0000899869 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnotes

Disclosed balance after: 27,595,589

F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.71 to $7.87. The Reporting Person undertakes to provide the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F1 · ownership.nature: This statement on Form 4 is being jointly filed by The Baupost Group, L.L.C. ("Baupost"), Baupost Group GP, L.L.C. ("Baupost GP"), and Seth A. Klarman ("Mr. Klarman") (collectively, the "Reporting Persons"). Baupost is a registered investment adviser. The principal business of Baupost is to act as an investment adviser to various private investment limited partnerships. Baupost GP, as the manager of Baupost, and Mr. Klarman, as the sole managing member of Baupost GP and a controlling person of Baupost, may be deemed to have beneficial ownership under Section 13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), of the securities beneficially owned by Baupost. Securities reported on this Form 4 as being beneficially owned by Baupost were purchased on behalf of certain of such partnerships.

F2 · ownership.nature: (Continued from footnote 1) The Reporting Persons disclaim beneficial ownership of the securities indicated except to the extent of their pecuniary interest therein, and the reporting herein of such securities shall not be construed as an admission that the Reporting Persons are the beneficial owners thereof for purposes of Section 16 of the Exchange Act or for any other purpose.

Read SEC document
June 13, 2023 Filed Jun 15, 2023 19:36 UTC Garrett Motion Inc. GTX · Entity 1720 ConversionSeries A Cumulative Convertible Preferred Stock · Derivative 25,462,810 Not disclosed Not disclosed
Disclosure

SEC source: 0001140361-23-030150 · form4.xml · derivative · entry 5

BAUPOST GROUP LLC/MA · CIK 0001061768 · 10% owner

Baupost Group GP, L.L.C. · CIK 0001738693 · 10% owner

KLARMAN SETH A · CIK 0000899869 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnotes

Disclosed balance after: 0

Underlying: Common Stock · 28,120,589 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The common stock reported herein were issued following the automatic conversion of all outstanding the Series A Cumulative Convertible Preferred Stock of Garrett Motion Inc. (the "Conversion") in accordance with the Issuer's certificate of designations for the Series A Cumulative Convertible Preferred Stock.

F3 · price: The common stock reported herein were issued following the automatic conversion of all outstanding the Series A Cumulative Convertible Preferred Stock of Garrett Motion Inc. (the "Conversion") in accordance with the Issuer's certificate of designations for the Series A Cumulative Convertible Preferred Stock.

F3 · derivative.exercise_date: The common stock reported herein were issued following the automatic conversion of all outstanding the Series A Cumulative Convertible Preferred Stock of Garrett Motion Inc. (the "Conversion") in accordance with the Issuer's certificate of designations for the Series A Cumulative Convertible Preferred Stock.

F3 · derivative.expiration_date: The common stock reported herein were issued following the automatic conversion of all outstanding the Series A Cumulative Convertible Preferred Stock of Garrett Motion Inc. (the "Conversion") in accordance with the Issuer's certificate of designations for the Series A Cumulative Convertible Preferred Stock.

F1 · ownership.nature: This statement on Form 4 is being jointly filed by The Baupost Group, L.L.C. ("Baupost"), Baupost Group GP, L.L.C. ("Baupost GP"), and Seth A. Klarman ("Mr. Klarman") (collectively, the "Reporting Persons"). Baupost is a registered investment adviser. The principal business of Baupost is to act as an investment adviser to various private investment limited partnerships. Baupost GP, as the manager of Baupost, and Mr. Klarman, as the sole managing member of Baupost GP and a controlling person of Baupost, may be deemed to have beneficial ownership under Section 13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), of the securities beneficially owned by Baupost. Securities reported on this Form 4 as being beneficially owned by Baupost were purchased on behalf of certain of such partnerships.

F2 · ownership.nature: (Continued from footnote 1) The Reporting Persons disclaim beneficial ownership of the securities indicated except to the extent of their pecuniary interest therein, and the reporting herein of such securities shall not be construed as an admission that the Reporting Persons are the beneficial owners thereof for purposes of Section 16 of the Exchange Act or for any other purpose.

Read SEC document
June 13, 2023 Filed Jun 15, 2023 19:36 UTC Garrett Motion Inc. GTX · Entity 1720 SaleCommon Stock 500,000 $8.00 $4,000,000.00
Disclosure

SEC source: 0001140361-23-030150 · form4.xml · nonDerivative · entry 2

BAUPOST GROUP LLC/MA · CIK 0001061768 · 10% owner

Baupost Group GP, L.L.C. · CIK 0001738693 · 10% owner

KLARMAN SETH A · CIK 0000899869 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnotes

Disclosed balance after: 30,695,589

F1 · ownership.nature: This statement on Form 4 is being jointly filed by The Baupost Group, L.L.C. ("Baupost"), Baupost Group GP, L.L.C. ("Baupost GP"), and Seth A. Klarman ("Mr. Klarman") (collectively, the "Reporting Persons"). Baupost is a registered investment adviser. The principal business of Baupost is to act as an investment adviser to various private investment limited partnerships. Baupost GP, as the manager of Baupost, and Mr. Klarman, as the sole managing member of Baupost GP and a controlling person of Baupost, may be deemed to have beneficial ownership under Section 13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), of the securities beneficially owned by Baupost. Securities reported on this Form 4 as being beneficially owned by Baupost were purchased on behalf of certain of such partnerships.

F2 · ownership.nature: (Continued from footnote 1) The Reporting Persons disclaim beneficial ownership of the securities indicated except to the extent of their pecuniary interest therein, and the reporting herein of such securities shall not be construed as an admission that the Reporting Persons are the beneficial owners thereof for purposes of Section 16 of the Exchange Act or for any other purpose.

Read SEC document
June 13, 2023 Filed Jun 15, 2023 19:36 UTC Garrett Motion Inc. GTX · Entity 1720 ConversionCommon Stock 25,462,810 Not disclosed Not disclosed
Disclosure

SEC source: 0001140361-23-030150 · form4.xml · nonDerivative · entry 1

BAUPOST GROUP LLC/MA · CIK 0001061768 · 10% owner

Baupost Group GP, L.L.C. · CIK 0001738693 · 10% owner

KLARMAN SETH A · CIK 0000899869 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnotes

Disclosed balance after: 31,195,589

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · price: The common stock reported herein were issued following the automatic conversion of all outstanding the Series A Cumulative Convertible Preferred Stock of Garrett Motion Inc. (the "Conversion") in accordance with the Issuer's certificate of designations for the Series A Cumulative Convertible Preferred Stock.

F1 · ownership.nature: This statement on Form 4 is being jointly filed by The Baupost Group, L.L.C. ("Baupost"), Baupost Group GP, L.L.C. ("Baupost GP"), and Seth A. Klarman ("Mr. Klarman") (collectively, the "Reporting Persons"). Baupost is a registered investment adviser. The principal business of Baupost is to act as an investment adviser to various private investment limited partnerships. Baupost GP, as the manager of Baupost, and Mr. Klarman, as the sole managing member of Baupost GP and a controlling person of Baupost, may be deemed to have beneficial ownership under Section 13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), of the securities beneficially owned by Baupost. Securities reported on this Form 4 as being beneficially owned by Baupost were purchased on behalf of certain of such partnerships.

F2 · ownership.nature: (Continued from footnote 1) The Reporting Persons disclaim beneficial ownership of the securities indicated except to the extent of their pecuniary interest therein, and the reporting herein of such securities shall not be construed as an admission that the Reporting Persons are the beneficial owners thereof for purposes of Section 16 of the Exchange Act or for any other purpose.

Read SEC document
June 08, 2023 Filed Jun 12, 2023 19:09 UTC Garrett Motion Inc. GTX · Entity 1720 SaleSeries A Preferred Stock · Derivative 17,482 Not disclosed Not disclosed
Disclosure

SEC source: 0001140361-23-029345 · form4.xml · derivative · entry 2

BAUPOST GROUP LLC/MA · CIK 0001061768 · 10% owner

KLARMAN SETH A · CIK 0000899869 · 10% owner

Baupost Group GP, L.L.C. · CIK 0001738693 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnotes

Disclosed balance after: 25,462,810

Underlying: Common Stock, par value$.001per share · 17,482 shares

Expires not disclosed

F3 · derivative.exercise_price: Shares of Series A Preferred Stock of Garrett Motion Inc. (the "Company") are convertible, at the holder's election, at the conversion rate (as defined in the Company's certificate of designation of Series A Convertible Preferred Stock), which initially is 1:1. The shares of Series A Preferred Stock have no expiration date.

F3 · shares: Shares of Series A Preferred Stock of Garrett Motion Inc. (the "Company") are convertible, at the holder's election, at the conversion rate (as defined in the Company's certificate of designation of Series A Convertible Preferred Stock), which initially is 1:1. The shares of Series A Preferred Stock have no expiration date.

F3 · price: Shares of Series A Preferred Stock of Garrett Motion Inc. (the "Company") are convertible, at the holder's election, at the conversion rate (as defined in the Company's certificate of designation of Series A Convertible Preferred Stock), which initially is 1:1. The shares of Series A Preferred Stock have no expiration date.

F3 · derivative.exercise_date: Shares of Series A Preferred Stock of Garrett Motion Inc. (the "Company") are convertible, at the holder's election, at the conversion rate (as defined in the Company's certificate of designation of Series A Convertible Preferred Stock), which initially is 1:1. The shares of Series A Preferred Stock have no expiration date.

F3 · derivative.expiration_date: Shares of Series A Preferred Stock of Garrett Motion Inc. (the "Company") are convertible, at the holder's election, at the conversion rate (as defined in the Company's certificate of designation of Series A Convertible Preferred Stock), which initially is 1:1. The shares of Series A Preferred Stock have no expiration date.

F3 · derivative.underlying_shares: Shares of Series A Preferred Stock of Garrett Motion Inc. (the "Company") are convertible, at the holder's election, at the conversion rate (as defined in the Company's certificate of designation of Series A Convertible Preferred Stock), which initially is 1:1. The shares of Series A Preferred Stock have no expiration date.

F1 · ownership.nature: This statement on Form 4 is being jointly filed by The Baupost Group, L.L.C. ("Baupost"), Baupost Group GP, L.L.C. ("Baupost GP"), and Seth A. Klarman ("Mr. Klarman") (collectively, the "Reporting Persons"). Baupost is a registered investment adviser. The principal business of Baupost is to act as an investment adviser to various private investment limited partnerships. Baupost GP, as the manager of Baupost, and Mr. Klarman, as the sole managing member of Baupost GP and a controlling person of Baupost, may be deemed to have beneficial ownership under Section 13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), of the securities beneficially owned by Baupost. Securities reported on this Form 4 as being beneficially owned by Baupost were purchased on behalf of certain of such partnerships.

F2 · ownership.nature: (Continued from footnote 1) The Reporting Persons disclaim beneficial ownership of the securities indicated except to the extent of their pecuniary interest therein, and the reporting herein of such securities shall not be construed as an admission that the Reporting Persons are the beneficial owners thereof for purposes of Section 16 of the Exchange Act or for any other purpose.

Read SEC document
June 08, 2023 Filed Jun 12, 2023 19:09 UTC Garrett Motion Inc. GTX · Entity 1720 SaleCommon Stock 500,000 $8.20 $4,100,000.00
Disclosure

SEC source: 0001140361-23-029345 · form4.xml · nonDerivative · entry 1

BAUPOST GROUP LLC/MA · CIK 0001061768 · 10% owner

KLARMAN SETH A · CIK 0000899869 · 10% owner

Baupost Group GP, L.L.C. · CIK 0001738693 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnotes

Disclosed balance after: 3,075,000

F1 · ownership.nature: This statement on Form 4 is being jointly filed by The Baupost Group, L.L.C. ("Baupost"), Baupost Group GP, L.L.C. ("Baupost GP"), and Seth A. Klarman ("Mr. Klarman") (collectively, the "Reporting Persons"). Baupost is a registered investment adviser. The principal business of Baupost is to act as an investment adviser to various private investment limited partnerships. Baupost GP, as the manager of Baupost, and Mr. Klarman, as the sole managing member of Baupost GP and a controlling person of Baupost, may be deemed to have beneficial ownership under Section 13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), of the securities beneficially owned by Baupost. Securities reported on this Form 4 as being beneficially owned by Baupost were purchased on behalf of certain of such partnerships.

F2 · ownership.nature: (Continued from footnote 1) The Reporting Persons disclaim beneficial ownership of the securities indicated except to the extent of their pecuniary interest therein, and the reporting herein of such securities shall not be construed as an admission that the Reporting Persons are the beneficial owners thereof for purposes of Section 16 of the Exchange Act or for any other purpose.

Read SEC document
December 10, 2021 Filed Dec 14, 2021 17:30 UTC Garrett Motion Inc. GTX · Entity 1720 SaleSeries A Preferred Stock · Derivative 1,827,868 $8.20 $14,988,517.60
Disclosure

SEC source: 0001567619-21-022047 · doc1.xml · derivative · entry 2

BAUPOST GROUP LLC/MA · CIK 0001061768 · 10% owner

Baupost Group GP, L.L.C. · CIK 0001738693 · 10% owner

KLARMAN SETH A · CIK 0000899869 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 25,480,292

Underlying: Common Stock, par value $0.001 per share · 1,827,868 shares

Expires not disclosed

F3 · derivative.exercise_price: Shares of Series A Preferred Stock are convertible, at the holder's election, at the conversion rate (as defined in the Company's certificate of designation of Series A Preferred Stock), which initially is 1:1. The shares of Series A Preferred Stock have no expiration date.

F3 · derivative.exercise_date: Shares of Series A Preferred Stock are convertible, at the holder's election, at the conversion rate (as defined in the Company's certificate of designation of Series A Preferred Stock), which initially is 1:1. The shares of Series A Preferred Stock have no expiration date.

F3 · derivative.expiration_date: Shares of Series A Preferred Stock are convertible, at the holder's election, at the conversion rate (as defined in the Company's certificate of designation of Series A Preferred Stock), which initially is 1:1. The shares of Series A Preferred Stock have no expiration date.

F3 · derivative.underlying_shares: Shares of Series A Preferred Stock are convertible, at the holder's election, at the conversion rate (as defined in the Company's certificate of designation of Series A Preferred Stock), which initially is 1:1. The shares of Series A Preferred Stock have no expiration date.

F1 · ownership.nature: This statement on Form 4 is being jointly filed by The Baupost Group, L.L.C. ("Baupost"), Baupost Group GP, L.L.C. ("Baupost GP") and Seth A. Klarman ("Mr. Klarman") (collectively, the "Reporting Persons"). Baupost is a registered investment adviser. The principal business of Baupost is to act as an investment adviser to various private investment limited partnerships. Baupost GP, as the manager of Baupost, and Mr. Klarman, as the sole managing member of Baupost GP and a controlling person of Baupost, may be deemed to have beneficial ownership under Section 13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), of the securities beneficially owned by Baupost. Securities reported on this Form 4 as being beneficially owned by Baupost were purchased on behalf of certain of such partnerships.

F2 · ownership.nature: (Continued from footnote 1) The Reporting Persons disclaim beneficial ownership of the securities indicated except to the extent of their pecuniary interest therein, and the reporting herein of such securities shall not be construed as an admission that the Reporting Persons are the beneficial owners thereof for purposes of Section 16 of the Exchange Act or for any other purpose.

Read SEC document
September 14, 2021 Filed Sep 16, 2021 17:43 UTC Amendment Translate Bio, Inc. TBIO · Entity 135439 OtherCommon Stock 18,044,239 $38.00 $685,681,082.00
Disclosure

SEC source: 0001567619-21-017206 · doc1.xml · nonDerivative · entry 1

BAUPOST GROUP LLC/MA · CIK 0001061768 · 10% owner

Baupost Group GP, L.L.C. · CIK 0001738693 · 10% owner

KLARMAN SETH A · CIK 0000899869 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote 1 and 2

Disclosed balance after: 0

F3 · kind: On September 14, 2021, the Agreement and Plan of Merger among Sanofi, Vector Merger Sub Inc. and Translate Bio Inc. ("Merger Agreement") was consummated and Sanofi completed its acquisition of the Issuer as described in the 8-K filed by the Issuer on September 14, 2021, and incorporated herein by reference. In connection with the consummation of the merger, all shares of Common Stock of the Issuer held by the Reporting Persons were acquired at the tender offer price of $38.00 per share.

F1 · ownership.nature: This statement on Form 4 is being jointly filed by The Baupost Group, L.L.C. ("Baupost"), Baupost Group GP, L.L.C. ("BG GP") and Seth A. Klarman ("Mr. Klarman") (collectively, the "Reporting Persons"). Baupost is a registered investment adviser. The principal business of Baupost is to act as an investment adviser to various private investment limited partnerships. BG GP, as the manager of Baupost, and Mr. Klarman, as the sole managing member of BG GP and a controlling person of Baupost, may be deemed to have beneficial ownership under Section 13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), of the securities beneficially owned by Baupost. Securities reported on this Form 4 as being beneficially owned by Baupost were purchased on behalf of certain of such partnerships.

F2 · ownership.nature: (Continued from Footnote 1) The Reporting Persons disclaim beneficial ownership of the securities indicated except to the extent of their pecuniary interest therein, and the reporting herein of such securities shall not be construed as an admission that the Reporting Persons are the beneficial owners thereof for purposes of Section 16 of the Exchange Act or for any other purpose.

Read SEC document
May 11, 2021 Filed May 13, 2021 16:18 UTC Garrett Motion Inc. GTX · Entity 1720 SaleSeries A Preferred Stock · Derivative 761,905 Not disclosed Not disclosed
Disclosure

SEC source: 0001567619-21-009872 · doc1.xml · derivative · entry 2

BAUPOST GROUP LLC/MA · CIK 0001061768 · 10% owner

Baupost Group GP, L.L.C. · CIK 0001738693 · 10% owner

KLARMAN SETH A · CIK 0000899869 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 27,308,160

Underlying: Common Stock, par value $0.001 per share · 761,905 shares

Expires not disclosed

F3 · derivative.exercise_price: Shares of Series A Preferred Stock of Garrett Motion Inc. (the "Company") are convertible, at the holder's election, at the conversion rate (as defined in the Company's certificate of designation of Series A Convertible Preferred Stock), which initially is 1:1. The shares of Series A Preferred Stock have no expiration date.

F3 · shares: Shares of Series A Preferred Stock of Garrett Motion Inc. (the "Company") are convertible, at the holder's election, at the conversion rate (as defined in the Company's certificate of designation of Series A Convertible Preferred Stock), which initially is 1:1. The shares of Series A Preferred Stock have no expiration date.

F3 · price: Shares of Series A Preferred Stock of Garrett Motion Inc. (the "Company") are convertible, at the holder's election, at the conversion rate (as defined in the Company's certificate of designation of Series A Convertible Preferred Stock), which initially is 1:1. The shares of Series A Preferred Stock have no expiration date.

F3 · derivative.exercise_date: Shares of Series A Preferred Stock of Garrett Motion Inc. (the "Company") are convertible, at the holder's election, at the conversion rate (as defined in the Company's certificate of designation of Series A Convertible Preferred Stock), which initially is 1:1. The shares of Series A Preferred Stock have no expiration date.

F3 · derivative.expiration_date: Shares of Series A Preferred Stock of Garrett Motion Inc. (the "Company") are convertible, at the holder's election, at the conversion rate (as defined in the Company's certificate of designation of Series A Convertible Preferred Stock), which initially is 1:1. The shares of Series A Preferred Stock have no expiration date.

F3 · derivative.underlying_shares: Shares of Series A Preferred Stock of Garrett Motion Inc. (the "Company") are convertible, at the holder's election, at the conversion rate (as defined in the Company's certificate of designation of Series A Convertible Preferred Stock), which initially is 1:1. The shares of Series A Preferred Stock have no expiration date.

F1 · ownership.nature: This statement on Form 4 is being jointly filed by The Baupost Group, L.L.C. ("Baupost"), Baupost Group GP, L.L.C. ("Baupost GP") and Seth A. Klarman ("Mr. Klarman") (collectively, the "Reporting Persons"). Baupost is a registered investment adviser. The principal business of Baupost is to act as an investment adviser to various private investment limited partnerships. Baupost GP, as the manager of Baupost, and Mr. Klarman, as the sole managing member of Baupost GP and a controlling person of Baupost, may be deemed to have beneficial ownership under Section 13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), of the securities beneficially owned by Baupost. Securities reported on this Form 4 as being beneficially owned by Baupost were purchased on behalf of certain of such partnerships.

F2 · ownership.nature: (Continued from footnote 1) The Reporting Persons disclaim beneficial ownership of the securities indicated except to the extent of their pecuniary interest therein, and the reporting herein of such securities shall not be construed as an admission that the Reporting Persons are the beneficial owners thereof for purposes of Section 16 of the Exchange Act or for any other purpose.

Read SEC document
May 07, 2021 Filed May 11, 2021 15:43 UTC Garrett Motion Inc. GTX · Entity 1720 SaleSeries A Preferred Stock · Derivative 380,952 Not disclosed Not disclosed
Disclosure

SEC source: 0001567619-21-009558 · doc1.xml · derivative · entry 2

BAUPOST GROUP LLC/MA · CIK 0001061768 · 10% owner

Baupost Group GP, L.L.C. · CIK 0001738693 · 10% owner

KLARMAN SETH A · CIK 0000899869 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 28,070,065

Underlying: Common Stock, par value $0.001 per share · 380,952 shares

Expires not disclosed

F3 · derivative.exercise_price: Shares of Series A Preferred Stock of Garrett Motion Inc. (the "Company") are convertible, at the holder's election, at the conversion rate (as defined in the Company's certificate of designation of Series A Convertible Preferred Stock), which initially is 1:1. The shares of Series A Preferred Stock have no expiration date.

F3 · shares: Shares of Series A Preferred Stock of Garrett Motion Inc. (the "Company") are convertible, at the holder's election, at the conversion rate (as defined in the Company's certificate of designation of Series A Convertible Preferred Stock), which initially is 1:1. The shares of Series A Preferred Stock have no expiration date.

F3 · price: Shares of Series A Preferred Stock of Garrett Motion Inc. (the "Company") are convertible, at the holder's election, at the conversion rate (as defined in the Company's certificate of designation of Series A Convertible Preferred Stock), which initially is 1:1. The shares of Series A Preferred Stock have no expiration date.

F3 · derivative.exercise_date: Shares of Series A Preferred Stock of Garrett Motion Inc. (the "Company") are convertible, at the holder's election, at the conversion rate (as defined in the Company's certificate of designation of Series A Convertible Preferred Stock), which initially is 1:1. The shares of Series A Preferred Stock have no expiration date.

F3 · derivative.expiration_date: Shares of Series A Preferred Stock of Garrett Motion Inc. (the "Company") are convertible, at the holder's election, at the conversion rate (as defined in the Company's certificate of designation of Series A Convertible Preferred Stock), which initially is 1:1. The shares of Series A Preferred Stock have no expiration date.

F3 · derivative.underlying_shares: Shares of Series A Preferred Stock of Garrett Motion Inc. (the "Company") are convertible, at the holder's election, at the conversion rate (as defined in the Company's certificate of designation of Series A Convertible Preferred Stock), which initially is 1:1. The shares of Series A Preferred Stock have no expiration date.

F1 · ownership.nature: This statement on Form 4 is being jointly filed by The Baupost Group, L.L.C. ("Baupost"), Baupost Group GP, L.L.C. ("Baupost GP") and Seth A. Klarman ("Mr. Klarman") (collectively, the "Reporting Persons"). Baupost is a registered investment adviser. The principal business of Baupost is to act as an investment adviser to various private investment limited partnerships. Baupost GP, as the manager of Baupost, and Mr. Klarman, as the sole managing member of Baupost GP and a controlling person of Baupost, may be deemed to have beneficial ownership under Section 13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), of the securities beneficially owned by Baupost. Securities reported on this Form 4 as being beneficially owned by Baupost were purchased on behalf of certain of such partnerships.

F2 · ownership.nature: (Continued from footnote 1) The Reporting Persons disclaim beneficial ownership of the securities indicated except to the extent of their pecuniary interest therein, and the reporting herein of such securities shall not be construed as an admission that the Reporting Persons are the beneficial owners thereof for purposes of Section 16 of the Exchange Act or for any other purpose.

Read SEC document
April 30, 2021 Filed May 4, 2021 18:02 UTC Garrett Motion Inc. GTX · Entity 1720 OtherCommon Stock 3,575,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001567619-21-009012 · doc1.xml · nonDerivative · entry 1

BAUPOST GROUP LLC/MA · CIK 0001061768 · Maybe a member of 10% group

Baupost Group GP, L.L.C. · CIK 0001738693 · 10% owner

KLARMAN SETH A · CIK 0000899869 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 0

F3 · kind: On September 20, 2020, Garrett Motion Inc. (the "Issuer") and certain of its subsidiaries (collectively, the "Debtors") each filed a voluntary petition for relief under chapter 11 of title 11 of the United States Code (the "Bankruptcy Code") in the United States Bankruptcy Court for the Southern District of New York (the "Bankruptcy Court"). On April 26, 2021, the Debtors filed an amended Chapter 11 plan of reorganization (the "Plan") and on April 9, 2021, the Issuer filed a supplement to the Plan (as amended on April 20, 2021 and April 22, 2021, the "Plan Supplement") with the Bankruptcy Court. On April 26, 2021, the Bankruptcy Court entered an order confirming the Plan (the "Confirmation Order") and, on April 30, 2021 (the "Effective Date") the conditions to effectiveness of the Plan were satisfied or waived and the Issuer emerged from bankruptcy.

F4 · kind: (Continued from footnote 3) On the Effective Date, all outstanding shares of the Issuer's common stock outstanding prior to the Effective Date were canceled, released, and extinguished, and of no further force or effect and without any need for a holder of such common stock to take further action with respect thereto. Accordingly, this Form 4 shall constitute an exit filing for the Reporting Persons with respect to the Issuer.

F3 · price: On September 20, 2020, Garrett Motion Inc. (the "Issuer") and certain of its subsidiaries (collectively, the "Debtors") each filed a voluntary petition for relief under chapter 11 of title 11 of the United States Code (the "Bankruptcy Code") in the United States Bankruptcy Court for the Southern District of New York (the "Bankruptcy Court"). On April 26, 2021, the Debtors filed an amended Chapter 11 plan of reorganization (the "Plan") and on April 9, 2021, the Issuer filed a supplement to the Plan (as amended on April 20, 2021 and April 22, 2021, the "Plan Supplement") with the Bankruptcy Court. On April 26, 2021, the Bankruptcy Court entered an order confirming the Plan (the "Confirmation Order") and, on April 30, 2021 (the "Effective Date") the conditions to effectiveness of the Plan were satisfied or waived and the Issuer emerged from bankruptcy.

F4 · price: (Continued from footnote 3) On the Effective Date, all outstanding shares of the Issuer's common stock outstanding prior to the Effective Date were canceled, released, and extinguished, and of no further force or effect and without any need for a holder of such common stock to take further action with respect thereto. Accordingly, this Form 4 shall constitute an exit filing for the Reporting Persons with respect to the Issuer.

F1 · ownership.nature: This statement on Form 4 is being jointly filed by The Baupost Group, L.L.C. ("Baupost"), Baupost Group GP, L.L.C. ("Baupost GP") and Seth A. Klarman ("Mr. Klarman") (collectively, the "Reporting Persons"). Baupost is a registered investment adviser. The principal business of Baupost is to act as an investment adviser to various private investment limited partnerships. Baupost GP, as the manager of Baupost, and Mr. Klarman, as the sole managing member of Baupost GP and a controlling person of Baupost, may be deemed to have beneficial ownership under Section 13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), of the securities beneficially owned by Baupost. Securities reported on this Form 3 as being beneficially owned by Baupost were purchased on behalf of certain of such partnerships.

F2 · ownership.nature: (Continued from footnote 1) The Reporting Persons disclaim beneficial ownership of the securities indicated except to the extent of their pecuniary interest therein, and the reporting herein of such securities shall not be construed as an admission that the Reporting Persons are the beneficial owners thereof for purposes of Section 16 of the Exchange Act or for any other purpose.

Read SEC document
July 23, 2020 Filed Jul 27, 2020 21:03 UTC VIASAT INC VSAT · Entity 1744 PurchaseCommon Stock 2,556,891 $39.11 $100,000,007.01
Disclosure

SEC source: 0001567619-20-013767 · doc1.xml · nonDerivative · entry 1

BAUPOST GROUP LLC/MA · CIK 0001061768 · 10% owner

KLARMAN SETH A · CIK 0000899869 · 10% owner

Baupost Group GP, L.L.C. · CIK 0001738693 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote 1.

Disclosed balance after: 16,288,959

F1 · ownership.nature: This statement on Form 4 is being jointly filed by The Baupost Group, L.L.C. ("Baupost"), Baupost Group GP, L.L.C. ("Baupost GP") and Seth A. Klarman ("Mr. Klarman") (collectively, the "Reporting Persons"). Baupost is a registered investment adviser. The principal business of Baupost is to act as an investment adviser to various private investment limited partnerships. Baupost GP, as the manager of Baupost, and Mr. Klarman, as the sole managing member of Baupost GP and a controlling person of Baupost, may be deemed to have beneficial ownership under Section 13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), of the securities beneficially owned by Baupost. Securities reported on this Form 4 as being beneficially owned by Baupost were purchased on behalf of certain of such partnerships.

F2 · ownership.nature: (Continued from footnote 1) The Reporting Persons disclaim beneficial ownership of the securities indicated except to the extent of their pecuniary therein, and the reporting herein of such securities shall not be construed as an admission that the Reporting Persons are the beneficial owners thereof for purpose of Section 16 or for any other purpose.

Read SEC document
June 26, 2020 Filed Jun 30, 2020 17:37 UTC Translate Bio, Inc. TBIO · Entity 135439 PurchaseCommon Stock 500,000 $22.00 $11,000,000.00
Disclosure

SEC source: 0001567619-20-012703 · doc1.xml · nonDerivative · entry 1

BAUPOST GROUP LLC/MA · CIK 0001061768 · 10% owner

Baupost Group GP, L.L.C. · CIK 0001738693 · 10% owner

KLARMAN SETH A · CIK 0000899869 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote 1 and 2.

Disclosed balance after: 18,044,239

F1 · ownership.nature: This statement on Form 4 is being jointly filed by The Baupost Group, L.L.C. ("Baupost"), Baupost Group GP, L.L.C. ("BG GP") and Seth A. Klarman ("Mr. Klarman") (collectively, the "Reporting Persons"). Baupost is a registered investment adviser. The principal business of Baupost is to act as an investment adviser to various private investment limited partnerships. BG GP, as the manager of Baupost, and Mr. Klarman, as the sole managing member of BG GP and a controlling person of Baupost, may be deemed to have beneficial ownership under Section 13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), of the securities beneficially owned by Baupost. Securities reported on this Form 4 as being beneficially owned by Baupost were purchased on behalf of certain of such partnerships.

F2 · ownership.nature: (Continued from Footnote 1) The Reporting Persons disclaim beneficial ownership of the securities indicated except to the extent of their pecuniary interest therein, and the reporting herein of such securities shall not be construed as an admission that the Reporting Persons are the beneficial owners thereof for purposes of Section 16 of the Exchange Act or for any other purpose.

Read SEC document
May 31, 2019 Filed Jun 4, 2019 16:57 UTC Orexigen Therapeutics, Inc. OREXQ · Entity 157016 OtherWarrant Expiring 2026 · Derivative 100,000,000 Not disclosed Strike: $15.00 Not disclosed
Disclosure

SEC source: 0001567619-19-012688 · doc1.xml · derivative · entry 3

BAUPOST GROUP LLC/MA · CIK 0001061768 · 10% owner

Baupost Group GP, L.L.C. · CIK 0001738693 · 10% owner

KLARMAN SETH A · CIK 0000899869 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

Underlying: Common Stock · 10,000,000 shares

Expires 2026-09-21

F3 · derivative.exercise_price: Such aggregate principal amount of the 0% Senior Secured Convertible Notes due 2020 ("Notes") were converted into post-petition secured obligations under a debtor-in-possession credit facility entered into on March 12, 2018 and approved by the United States Bankruptcy Court for the District of Delaware (the "Bankruptcy Court") on April 13, 2018. At such time 7,802,197 shares of Common Stock were underlying the remaining outstanding aggregate principal amount of the Notes. On May 31, 2019, the Issuer's Modified Amended Plan of Liquidation (the "Plan of Liquidation"), which was confirmed by the Bankruptcy Court on May 17, 2019, became effective. As provided by the Plan of Liquidation, the Reporting Persons surrendered the Notes in exchange for a pro rata distribution of the Issuer's distributable cash, cash proceeds from tax refunds and unused amounts of wind down reserves, each as defined in the Plan of Liquidation.

F3 · kind: Such aggregate principal amount of the 0% Senior Secured Convertible Notes due 2020 ("Notes") were converted into post-petition secured obligations under a debtor-in-possession credit facility entered into on March 12, 2018 and approved by the United States Bankruptcy Court for the District of Delaware (the "Bankruptcy Court") on April 13, 2018. At such time 7,802,197 shares of Common Stock were underlying the remaining outstanding aggregate principal amount of the Notes. On May 31, 2019, the Issuer's Modified Amended Plan of Liquidation (the "Plan of Liquidation"), which was confirmed by the Bankruptcy Court on May 17, 2019, became effective. As provided by the Plan of Liquidation, the Reporting Persons surrendered the Notes in exchange for a pro rata distribution of the Issuer's distributable cash, cash proceeds from tax refunds and unused amounts of wind down reserves, each as defined in the Plan of Liquidation.

F4 · kind: (Continued from footnote 3)The Plan of Liquidation also provided that all outstanding equity interests would be cancelled for no consideration on the effective date.

F3 · shares: Such aggregate principal amount of the 0% Senior Secured Convertible Notes due 2020 ("Notes") were converted into post-petition secured obligations under a debtor-in-possession credit facility entered into on March 12, 2018 and approved by the United States Bankruptcy Court for the District of Delaware (the "Bankruptcy Court") on April 13, 2018. At such time 7,802,197 shares of Common Stock were underlying the remaining outstanding aggregate principal amount of the Notes. On May 31, 2019, the Issuer's Modified Amended Plan of Liquidation (the "Plan of Liquidation"), which was confirmed by the Bankruptcy Court on May 17, 2019, became effective. As provided by the Plan of Liquidation, the Reporting Persons surrendered the Notes in exchange for a pro rata distribution of the Issuer's distributable cash, cash proceeds from tax refunds and unused amounts of wind down reserves, each as defined in the Plan of Liquidation.

F4 · shares: (Continued from footnote 3)The Plan of Liquidation also provided that all outstanding equity interests would be cancelled for no consideration on the effective date.

F3 · price: Such aggregate principal amount of the 0% Senior Secured Convertible Notes due 2020 ("Notes") were converted into post-petition secured obligations under a debtor-in-possession credit facility entered into on March 12, 2018 and approved by the United States Bankruptcy Court for the District of Delaware (the "Bankruptcy Court") on April 13, 2018. At such time 7,802,197 shares of Common Stock were underlying the remaining outstanding aggregate principal amount of the Notes. On May 31, 2019, the Issuer's Modified Amended Plan of Liquidation (the "Plan of Liquidation"), which was confirmed by the Bankruptcy Court on May 17, 2019, became effective. As provided by the Plan of Liquidation, the Reporting Persons surrendered the Notes in exchange for a pro rata distribution of the Issuer's distributable cash, cash proceeds from tax refunds and unused amounts of wind down reserves, each as defined in the Plan of Liquidation.

F4 · price: (Continued from footnote 3)The Plan of Liquidation also provided that all outstanding equity interests would be cancelled for no consideration on the effective date.

F3 · derivative.exercise_date: Such aggregate principal amount of the 0% Senior Secured Convertible Notes due 2020 ("Notes") were converted into post-petition secured obligations under a debtor-in-possession credit facility entered into on March 12, 2018 and approved by the United States Bankruptcy Court for the District of Delaware (the "Bankruptcy Court") on April 13, 2018. At such time 7,802,197 shares of Common Stock were underlying the remaining outstanding aggregate principal amount of the Notes. On May 31, 2019, the Issuer's Modified Amended Plan of Liquidation (the "Plan of Liquidation"), which was confirmed by the Bankruptcy Court on May 17, 2019, became effective. As provided by the Plan of Liquidation, the Reporting Persons surrendered the Notes in exchange for a pro rata distribution of the Issuer's distributable cash, cash proceeds from tax refunds and unused amounts of wind down reserves, each as defined in the Plan of Liquidation.

F4 · derivative.exercise_date: (Continued from footnote 3)The Plan of Liquidation also provided that all outstanding equity interests would be cancelled for no consideration on the effective date.

F3 · derivative.expiration_date: Such aggregate principal amount of the 0% Senior Secured Convertible Notes due 2020 ("Notes") were converted into post-petition secured obligations under a debtor-in-possession credit facility entered into on March 12, 2018 and approved by the United States Bankruptcy Court for the District of Delaware (the "Bankruptcy Court") on April 13, 2018. At such time 7,802,197 shares of Common Stock were underlying the remaining outstanding aggregate principal amount of the Notes. On May 31, 2019, the Issuer's Modified Amended Plan of Liquidation (the "Plan of Liquidation"), which was confirmed by the Bankruptcy Court on May 17, 2019, became effective. As provided by the Plan of Liquidation, the Reporting Persons surrendered the Notes in exchange for a pro rata distribution of the Issuer's distributable cash, cash proceeds from tax refunds and unused amounts of wind down reserves, each as defined in the Plan of Liquidation.

F4 · derivative.expiration_date: (Continued from footnote 3)The Plan of Liquidation also provided that all outstanding equity interests would be cancelled for no consideration on the effective date.

F3 · derivative.underlying_shares: Such aggregate principal amount of the 0% Senior Secured Convertible Notes due 2020 ("Notes") were converted into post-petition secured obligations under a debtor-in-possession credit facility entered into on March 12, 2018 and approved by the United States Bankruptcy Court for the District of Delaware (the "Bankruptcy Court") on April 13, 2018. At such time 7,802,197 shares of Common Stock were underlying the remaining outstanding aggregate principal amount of the Notes. On May 31, 2019, the Issuer's Modified Amended Plan of Liquidation (the "Plan of Liquidation"), which was confirmed by the Bankruptcy Court on May 17, 2019, became effective. As provided by the Plan of Liquidation, the Reporting Persons surrendered the Notes in exchange for a pro rata distribution of the Issuer's distributable cash, cash proceeds from tax refunds and unused amounts of wind down reserves, each as defined in the Plan of Liquidation.

F4 · derivative.underlying_shares: (Continued from footnote 3)The Plan of Liquidation also provided that all outstanding equity interests would be cancelled for no consideration on the effective date.

F1 · ownership.nature: This statement on Form 4 is being jointly filed by The Baupost Group, L.L.C. ("Baupost"), Baupost Group GP, L.L.C. ("BG GP"), and Seth A. Klarman (collectively, the "Reporting Persons"). Baupost is a registered investment adviser and acts as an investment adviser to various private investment limited partnerships. BG GP, as the Manager of Baupost, and Seth A. Klarman, as the Managing Member of BG GP and a controlling person of Baupost, may be deemed to have beneficial ownership under Section 13 of the Securities Exchange Act of 1934, as amended, of the securities beneficially owned by Baupost. Securities reported on this Form 4 as being beneficially owned by Baupost were purchased on behalf of certain of such partnerships.

F2 · ownership.nature: (Continued from footnote 1) The Reporting Persons disclaim beneficial ownership of the securities indicated except to the extent of their pecuniary therein, and the reporting herein of such securities shall not be construed as an admission that the Reporting Persons are the beneficial owners thereof for purpose of Section 16 or for any other purpose.

Read SEC document
May 31, 2019 Filed Jun 4, 2019 16:57 UTC Orexigen Therapeutics, Inc. OREXQ · Entity 157016 OtherWarrant Expiring 2020 · Derivative 5,000,000 Not disclosed Strike: $60.00 Not disclosed
Disclosure

SEC source: 0001567619-19-012688 · doc1.xml · derivative · entry 2

BAUPOST GROUP LLC/MA · CIK 0001061768 · 10% owner

Baupost Group GP, L.L.C. · CIK 0001738693 · 10% owner

KLARMAN SETH A · CIK 0000899869 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

Underlying: Common Stock · 500,000 shares

Expires 2020-09-10

F3 · derivative.exercise_price: Such aggregate principal amount of the 0% Senior Secured Convertible Notes due 2020 ("Notes") were converted into post-petition secured obligations under a debtor-in-possession credit facility entered into on March 12, 2018 and approved by the United States Bankruptcy Court for the District of Delaware (the "Bankruptcy Court") on April 13, 2018. At such time 7,802,197 shares of Common Stock were underlying the remaining outstanding aggregate principal amount of the Notes. On May 31, 2019, the Issuer's Modified Amended Plan of Liquidation (the "Plan of Liquidation"), which was confirmed by the Bankruptcy Court on May 17, 2019, became effective. As provided by the Plan of Liquidation, the Reporting Persons surrendered the Notes in exchange for a pro rata distribution of the Issuer's distributable cash, cash proceeds from tax refunds and unused amounts of wind down reserves, each as defined in the Plan of Liquidation.

F3 · kind: Such aggregate principal amount of the 0% Senior Secured Convertible Notes due 2020 ("Notes") were converted into post-petition secured obligations under a debtor-in-possession credit facility entered into on March 12, 2018 and approved by the United States Bankruptcy Court for the District of Delaware (the "Bankruptcy Court") on April 13, 2018. At such time 7,802,197 shares of Common Stock were underlying the remaining outstanding aggregate principal amount of the Notes. On May 31, 2019, the Issuer's Modified Amended Plan of Liquidation (the "Plan of Liquidation"), which was confirmed by the Bankruptcy Court on May 17, 2019, became effective. As provided by the Plan of Liquidation, the Reporting Persons surrendered the Notes in exchange for a pro rata distribution of the Issuer's distributable cash, cash proceeds from tax refunds and unused amounts of wind down reserves, each as defined in the Plan of Liquidation.

F4 · kind: (Continued from footnote 3)The Plan of Liquidation also provided that all outstanding equity interests would be cancelled for no consideration on the effective date.

F3 · shares: Such aggregate principal amount of the 0% Senior Secured Convertible Notes due 2020 ("Notes") were converted into post-petition secured obligations under a debtor-in-possession credit facility entered into on March 12, 2018 and approved by the United States Bankruptcy Court for the District of Delaware (the "Bankruptcy Court") on April 13, 2018. At such time 7,802,197 shares of Common Stock were underlying the remaining outstanding aggregate principal amount of the Notes. On May 31, 2019, the Issuer's Modified Amended Plan of Liquidation (the "Plan of Liquidation"), which was confirmed by the Bankruptcy Court on May 17, 2019, became effective. As provided by the Plan of Liquidation, the Reporting Persons surrendered the Notes in exchange for a pro rata distribution of the Issuer's distributable cash, cash proceeds from tax refunds and unused amounts of wind down reserves, each as defined in the Plan of Liquidation.

F4 · shares: (Continued from footnote 3)The Plan of Liquidation also provided that all outstanding equity interests would be cancelled for no consideration on the effective date.

F3 · price: Such aggregate principal amount of the 0% Senior Secured Convertible Notes due 2020 ("Notes") were converted into post-petition secured obligations under a debtor-in-possession credit facility entered into on March 12, 2018 and approved by the United States Bankruptcy Court for the District of Delaware (the "Bankruptcy Court") on April 13, 2018. At such time 7,802,197 shares of Common Stock were underlying the remaining outstanding aggregate principal amount of the Notes. On May 31, 2019, the Issuer's Modified Amended Plan of Liquidation (the "Plan of Liquidation"), which was confirmed by the Bankruptcy Court on May 17, 2019, became effective. As provided by the Plan of Liquidation, the Reporting Persons surrendered the Notes in exchange for a pro rata distribution of the Issuer's distributable cash, cash proceeds from tax refunds and unused amounts of wind down reserves, each as defined in the Plan of Liquidation.

F4 · price: (Continued from footnote 3)The Plan of Liquidation also provided that all outstanding equity interests would be cancelled for no consideration on the effective date.

F3 · derivative.exercise_date: Such aggregate principal amount of the 0% Senior Secured Convertible Notes due 2020 ("Notes") were converted into post-petition secured obligations under a debtor-in-possession credit facility entered into on March 12, 2018 and approved by the United States Bankruptcy Court for the District of Delaware (the "Bankruptcy Court") on April 13, 2018. At such time 7,802,197 shares of Common Stock were underlying the remaining outstanding aggregate principal amount of the Notes. On May 31, 2019, the Issuer's Modified Amended Plan of Liquidation (the "Plan of Liquidation"), which was confirmed by the Bankruptcy Court on May 17, 2019, became effective. As provided by the Plan of Liquidation, the Reporting Persons surrendered the Notes in exchange for a pro rata distribution of the Issuer's distributable cash, cash proceeds from tax refunds and unused amounts of wind down reserves, each as defined in the Plan of Liquidation.

F4 · derivative.exercise_date: (Continued from footnote 3)The Plan of Liquidation also provided that all outstanding equity interests would be cancelled for no consideration on the effective date.

F3 · derivative.expiration_date: Such aggregate principal amount of the 0% Senior Secured Convertible Notes due 2020 ("Notes") were converted into post-petition secured obligations under a debtor-in-possession credit facility entered into on March 12, 2018 and approved by the United States Bankruptcy Court for the District of Delaware (the "Bankruptcy Court") on April 13, 2018. At such time 7,802,197 shares of Common Stock were underlying the remaining outstanding aggregate principal amount of the Notes. On May 31, 2019, the Issuer's Modified Amended Plan of Liquidation (the "Plan of Liquidation"), which was confirmed by the Bankruptcy Court on May 17, 2019, became effective. As provided by the Plan of Liquidation, the Reporting Persons surrendered the Notes in exchange for a pro rata distribution of the Issuer's distributable cash, cash proceeds from tax refunds and unused amounts of wind down reserves, each as defined in the Plan of Liquidation.

F4 · derivative.expiration_date: (Continued from footnote 3)The Plan of Liquidation also provided that all outstanding equity interests would be cancelled for no consideration on the effective date.

F3 · derivative.underlying_shares: Such aggregate principal amount of the 0% Senior Secured Convertible Notes due 2020 ("Notes") were converted into post-petition secured obligations under a debtor-in-possession credit facility entered into on March 12, 2018 and approved by the United States Bankruptcy Court for the District of Delaware (the "Bankruptcy Court") on April 13, 2018. At such time 7,802,197 shares of Common Stock were underlying the remaining outstanding aggregate principal amount of the Notes. On May 31, 2019, the Issuer's Modified Amended Plan of Liquidation (the "Plan of Liquidation"), which was confirmed by the Bankruptcy Court on May 17, 2019, became effective. As provided by the Plan of Liquidation, the Reporting Persons surrendered the Notes in exchange for a pro rata distribution of the Issuer's distributable cash, cash proceeds from tax refunds and unused amounts of wind down reserves, each as defined in the Plan of Liquidation.

F4 · derivative.underlying_shares: (Continued from footnote 3)The Plan of Liquidation also provided that all outstanding equity interests would be cancelled for no consideration on the effective date.

F1 · ownership.nature: This statement on Form 4 is being jointly filed by The Baupost Group, L.L.C. ("Baupost"), Baupost Group GP, L.L.C. ("BG GP"), and Seth A. Klarman (collectively, the "Reporting Persons"). Baupost is a registered investment adviser and acts as an investment adviser to various private investment limited partnerships. BG GP, as the Manager of Baupost, and Seth A. Klarman, as the Managing Member of BG GP and a controlling person of Baupost, may be deemed to have beneficial ownership under Section 13 of the Securities Exchange Act of 1934, as amended, of the securities beneficially owned by Baupost. Securities reported on this Form 4 as being beneficially owned by Baupost were purchased on behalf of certain of such partnerships.

F2 · ownership.nature: (Continued from footnote 1) The Reporting Persons disclaim beneficial ownership of the securities indicated except to the extent of their pecuniary therein, and the reporting herein of such securities shall not be construed as an admission that the Reporting Persons are the beneficial owners thereof for purpose of Section 16 or for any other purpose.

Read SEC document
May 31, 2019 Filed Jun 4, 2019 16:57 UTC Orexigen Therapeutics, Inc. OREXQ · Entity 157016 Other0% Senior Secured Convertible Notes due 2020 · Derivative Not disclosed Not disclosed Strike: $7.50 $58,516,483.00
Disclosure

SEC source: 0001567619-19-012688 · doc1.xml · derivative · entry 1

BAUPOST GROUP LLC/MA · CIK 0001061768 · 10% owner

Baupost Group GP, L.L.C. · CIK 0001738693 · 10% owner

KLARMAN SETH A · CIK 0000899869 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

Underlying: Common Stock · 7,802,197 shares

Expires 2020-06-29

F3 · derivative.exercise_price: Such aggregate principal amount of the 0% Senior Secured Convertible Notes due 2020 ("Notes") were converted into post-petition secured obligations under a debtor-in-possession credit facility entered into on March 12, 2018 and approved by the United States Bankruptcy Court for the District of Delaware (the "Bankruptcy Court") on April 13, 2018. At such time 7,802,197 shares of Common Stock were underlying the remaining outstanding aggregate principal amount of the Notes. On May 31, 2019, the Issuer's Modified Amended Plan of Liquidation (the "Plan of Liquidation"), which was confirmed by the Bankruptcy Court on May 17, 2019, became effective. As provided by the Plan of Liquidation, the Reporting Persons surrendered the Notes in exchange for a pro rata distribution of the Issuer's distributable cash, cash proceeds from tax refunds and unused amounts of wind down reserves, each as defined in the Plan of Liquidation.

F4 · derivative.exercise_price: (Continued from footnote 3)The Plan of Liquidation also provided that all outstanding equity interests would be cancelled for no consideration on the effective date.

F3 · kind: Such aggregate principal amount of the 0% Senior Secured Convertible Notes due 2020 ("Notes") were converted into post-petition secured obligations under a debtor-in-possession credit facility entered into on March 12, 2018 and approved by the United States Bankruptcy Court for the District of Delaware (the "Bankruptcy Court") on April 13, 2018. At such time 7,802,197 shares of Common Stock were underlying the remaining outstanding aggregate principal amount of the Notes. On May 31, 2019, the Issuer's Modified Amended Plan of Liquidation (the "Plan of Liquidation"), which was confirmed by the Bankruptcy Court on May 17, 2019, became effective. As provided by the Plan of Liquidation, the Reporting Persons surrendered the Notes in exchange for a pro rata distribution of the Issuer's distributable cash, cash proceeds from tax refunds and unused amounts of wind down reserves, each as defined in the Plan of Liquidation.

F4 · kind: (Continued from footnote 3)The Plan of Liquidation also provided that all outstanding equity interests would be cancelled for no consideration on the effective date.

F3 · reported_value: Such aggregate principal amount of the 0% Senior Secured Convertible Notes due 2020 ("Notes") were converted into post-petition secured obligations under a debtor-in-possession credit facility entered into on March 12, 2018 and approved by the United States Bankruptcy Court for the District of Delaware (the "Bankruptcy Court") on April 13, 2018. At such time 7,802,197 shares of Common Stock were underlying the remaining outstanding aggregate principal amount of the Notes. On May 31, 2019, the Issuer's Modified Amended Plan of Liquidation (the "Plan of Liquidation"), which was confirmed by the Bankruptcy Court on May 17, 2019, became effective. As provided by the Plan of Liquidation, the Reporting Persons surrendered the Notes in exchange for a pro rata distribution of the Issuer's distributable cash, cash proceeds from tax refunds and unused amounts of wind down reserves, each as defined in the Plan of Liquidation.

F4 · reported_value: (Continued from footnote 3)The Plan of Liquidation also provided that all outstanding equity interests would be cancelled for no consideration on the effective date.

F3 · price: Such aggregate principal amount of the 0% Senior Secured Convertible Notes due 2020 ("Notes") were converted into post-petition secured obligations under a debtor-in-possession credit facility entered into on March 12, 2018 and approved by the United States Bankruptcy Court for the District of Delaware (the "Bankruptcy Court") on April 13, 2018. At such time 7,802,197 shares of Common Stock were underlying the remaining outstanding aggregate principal amount of the Notes. On May 31, 2019, the Issuer's Modified Amended Plan of Liquidation (the "Plan of Liquidation"), which was confirmed by the Bankruptcy Court on May 17, 2019, became effective. As provided by the Plan of Liquidation, the Reporting Persons surrendered the Notes in exchange for a pro rata distribution of the Issuer's distributable cash, cash proceeds from tax refunds and unused amounts of wind down reserves, each as defined in the Plan of Liquidation.

F4 · price: (Continued from footnote 3)The Plan of Liquidation also provided that all outstanding equity interests would be cancelled for no consideration on the effective date.

F3 · derivative.exercise_date: Such aggregate principal amount of the 0% Senior Secured Convertible Notes due 2020 ("Notes") were converted into post-petition secured obligations under a debtor-in-possession credit facility entered into on March 12, 2018 and approved by the United States Bankruptcy Court for the District of Delaware (the "Bankruptcy Court") on April 13, 2018. At such time 7,802,197 shares of Common Stock were underlying the remaining outstanding aggregate principal amount of the Notes. On May 31, 2019, the Issuer's Modified Amended Plan of Liquidation (the "Plan of Liquidation"), which was confirmed by the Bankruptcy Court on May 17, 2019, became effective. As provided by the Plan of Liquidation, the Reporting Persons surrendered the Notes in exchange for a pro rata distribution of the Issuer's distributable cash, cash proceeds from tax refunds and unused amounts of wind down reserves, each as defined in the Plan of Liquidation.

F4 · derivative.exercise_date: (Continued from footnote 3)The Plan of Liquidation also provided that all outstanding equity interests would be cancelled for no consideration on the effective date.

F3 · derivative.expiration_date: Such aggregate principal amount of the 0% Senior Secured Convertible Notes due 2020 ("Notes") were converted into post-petition secured obligations under a debtor-in-possession credit facility entered into on March 12, 2018 and approved by the United States Bankruptcy Court for the District of Delaware (the "Bankruptcy Court") on April 13, 2018. At such time 7,802,197 shares of Common Stock were underlying the remaining outstanding aggregate principal amount of the Notes. On May 31, 2019, the Issuer's Modified Amended Plan of Liquidation (the "Plan of Liquidation"), which was confirmed by the Bankruptcy Court on May 17, 2019, became effective. As provided by the Plan of Liquidation, the Reporting Persons surrendered the Notes in exchange for a pro rata distribution of the Issuer's distributable cash, cash proceeds from tax refunds and unused amounts of wind down reserves, each as defined in the Plan of Liquidation.

F4 · derivative.expiration_date: (Continued from footnote 3)The Plan of Liquidation also provided that all outstanding equity interests would be cancelled for no consideration on the effective date.

F3 · derivative.underlying_shares: Such aggregate principal amount of the 0% Senior Secured Convertible Notes due 2020 ("Notes") were converted into post-petition secured obligations under a debtor-in-possession credit facility entered into on March 12, 2018 and approved by the United States Bankruptcy Court for the District of Delaware (the "Bankruptcy Court") on April 13, 2018. At such time 7,802,197 shares of Common Stock were underlying the remaining outstanding aggregate principal amount of the Notes. On May 31, 2019, the Issuer's Modified Amended Plan of Liquidation (the "Plan of Liquidation"), which was confirmed by the Bankruptcy Court on May 17, 2019, became effective. As provided by the Plan of Liquidation, the Reporting Persons surrendered the Notes in exchange for a pro rata distribution of the Issuer's distributable cash, cash proceeds from tax refunds and unused amounts of wind down reserves, each as defined in the Plan of Liquidation.

F4 · derivative.underlying_shares: (Continued from footnote 3)The Plan of Liquidation also provided that all outstanding equity interests would be cancelled for no consideration on the effective date.

F1 · ownership.nature: This statement on Form 4 is being jointly filed by The Baupost Group, L.L.C. ("Baupost"), Baupost Group GP, L.L.C. ("BG GP"), and Seth A. Klarman (collectively, the "Reporting Persons"). Baupost is a registered investment adviser and acts as an investment adviser to various private investment limited partnerships. BG GP, as the Manager of Baupost, and Seth A. Klarman, as the Managing Member of BG GP and a controlling person of Baupost, may be deemed to have beneficial ownership under Section 13 of the Securities Exchange Act of 1934, as amended, of the securities beneficially owned by Baupost. Securities reported on this Form 4 as being beneficially owned by Baupost were purchased on behalf of certain of such partnerships.

F2 · ownership.nature: (Continued from footnote 1) The Reporting Persons disclaim beneficial ownership of the securities indicated except to the extent of their pecuniary therein, and the reporting herein of such securities shall not be construed as an admission that the Reporting Persons are the beneficial owners thereof for purpose of Section 16 or for any other purpose.

Read SEC document
December 12, 2018 Filed Dec 13, 2018 16:02 UTC KERYX BIOPHARMACEUTICALS INC KERX · Entity 161794 Disposition to issuerCommon Stock 65,374,013 Not disclosed Not disclosed
Disclosure

SEC source: 0001567619-18-007897 · doc1.xml · nonDerivative · entry 3

BAUPOST GROUP LLC/MA · CIK 0001061768 · Director · 10% owner

Baupost Group GP, L.L.C. · CIK 0001738693 · 10% owner

KLARMAN SETH A · CIK 0000899869 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote 1 and 2

Disclosed balance after: 0

F4 · price: Pursuant to the terms of the Merger Agreement, dated as of June 28, 2018, by and among Keryx Biopharmaceuticals, Inc., Akebia Therapeutics, Inc. and Alpha Therapeutics Merger Sub Inc., upon the closing of the Merger specified therein, all shares of Common Stock held by the Reporting Persons (including all shares of Common Stock issued pursuant to the terms of the Notes Conversion Agreement) converted into common stock, par value $0.00001 per share, of Akebia Therapeutics, Inc.

F1 · ownership.nature: This statement on Form 4 is being jointly filed by The Baupost Group, L.L.C. ("Baupost"), Baupost Group GP, LLC ("Baupost GP") and Seth A. Klarman ("Mr. Klarman") (collectively, the "Reporting Persons"). Baupost is a registered investment adviser. The principal business of Baupost is to act as an investment adviser to various private investment limited partnerships. Baupost GP, as the manager of Baupost, and Mr. Klarman, as the sole managing member of Baupost GP and a controlling person of Baupost, may be deemed to have beneficial ownership under Section 13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), of the securities beneficially owned by Baupost. Securities reported on this Form 4 as being beneficially owned by Baupost were purchased on behalf of certain of such partnerships.

F2 · ownership.nature: (Continued from footnote 1) The Reporting Persons disclaim beneficial ownership of the securities indicated except to the extent of their pecuniary interest therein, and the reporting herein of such securities shall not be construed as an admission that the Reporting Persons are the beneficial owners thereof for purposes of Section 16 of the Exchange Act or for any other purpose.

Read SEC document
December 11, 2018 Filed Dec 13, 2018 16:02 UTC KERYX BIOPHARMACEUTICALS INC KERX · Entity 161794 Exercise / conversionZero Coupon Senior Convertible Notes due 2021 · Derivative Not disclosed Not disclosed Strike: $4.63 $164,746,000.00
Disclosure

SEC source: 0001567619-18-007897 · doc1.xml · derivative · entry 4

BAUPOST GROUP LLC/MA · CIK 0001061768 · Director · 10% owner

Baupost Group GP, L.L.C. · CIK 0001738693 · 10% owner

KLARMAN SETH A · CIK 0000899869 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote 1 and 2

Disclosed balance after: 0

Underlying: Common Stock · 35,582,335 shares

Expires 2021-10-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · price: Pursuant to the terms of the Notes Conversion Agreement, dated as of June 28, 2018, by and among Keryx Biopharmaceuticals, Inc., Baupost Group Securities, L.L.C. and, with respect to certain sections only, Akebia Therapeutics, Inc., Baupost Group Securities, L.L.C. agreed to convert its Zero Coupon Senior Convertible Notes due 2021 pursuant to the terms of the governing indenture in exchange for, among other things, the receipt of 4,000,000 share of Common Stock.

F3 · derivative.underlying_shares: Pursuant to the terms of the Notes Conversion Agreement, dated as of June 28, 2018, by and among Keryx Biopharmaceuticals, Inc., Baupost Group Securities, L.L.C. and, with respect to certain sections only, Akebia Therapeutics, Inc., Baupost Group Securities, L.L.C. agreed to convert its Zero Coupon Senior Convertible Notes due 2021 pursuant to the terms of the governing indenture in exchange for, among other things, the receipt of 4,000,000 share of Common Stock.

F1 · ownership.nature: This statement on Form 4 is being jointly filed by The Baupost Group, L.L.C. ("Baupost"), Baupost Group GP, LLC ("Baupost GP") and Seth A. Klarman ("Mr. Klarman") (collectively, the "Reporting Persons"). Baupost is a registered investment adviser. The principal business of Baupost is to act as an investment adviser to various private investment limited partnerships. Baupost GP, as the manager of Baupost, and Mr. Klarman, as the sole managing member of Baupost GP and a controlling person of Baupost, may be deemed to have beneficial ownership under Section 13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), of the securities beneficially owned by Baupost. Securities reported on this Form 4 as being beneficially owned by Baupost were purchased on behalf of certain of such partnerships.

F2 · ownership.nature: (Continued from footnote 1) The Reporting Persons disclaim beneficial ownership of the securities indicated except to the extent of their pecuniary interest therein, and the reporting herein of such securities shall not be construed as an admission that the Reporting Persons are the beneficial owners thereof for purposes of Section 16 of the Exchange Act or for any other purpose.

Read SEC document
December 11, 2018 Filed Dec 13, 2018 16:02 UTC KERYX BIOPHARMACEUTICALS INC KERX · Entity 161794 GrantCommon Stock 4,000,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001567619-18-007897 · doc1.xml · nonDerivative · entry 2

BAUPOST GROUP LLC/MA · CIK 0001061768 · Director · 10% owner

Baupost Group GP, L.L.C. · CIK 0001738693 · 10% owner

KLARMAN SETH A · CIK 0000899869 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote 1 and 2

Disclosed balance after: 65,374,013

F3 · price: Pursuant to the terms of the Notes Conversion Agreement, dated as of June 28, 2018, by and among Keryx Biopharmaceuticals, Inc., Baupost Group Securities, L.L.C. and, with respect to certain sections only, Akebia Therapeutics, Inc., Baupost Group Securities, L.L.C. agreed to convert its Zero Coupon Senior Convertible Notes due 2021 pursuant to the terms of the governing indenture in exchange for, among other things, the receipt of 4,000,000 share of Common Stock.

F1 · ownership.nature: This statement on Form 4 is being jointly filed by The Baupost Group, L.L.C. ("Baupost"), Baupost Group GP, LLC ("Baupost GP") and Seth A. Klarman ("Mr. Klarman") (collectively, the "Reporting Persons"). Baupost is a registered investment adviser. The principal business of Baupost is to act as an investment adviser to various private investment limited partnerships. Baupost GP, as the manager of Baupost, and Mr. Klarman, as the sole managing member of Baupost GP and a controlling person of Baupost, may be deemed to have beneficial ownership under Section 13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), of the securities beneficially owned by Baupost. Securities reported on this Form 4 as being beneficially owned by Baupost were purchased on behalf of certain of such partnerships.

F2 · ownership.nature: (Continued from footnote 1) The Reporting Persons disclaim beneficial ownership of the securities indicated except to the extent of their pecuniary interest therein, and the reporting herein of such securities shall not be construed as an admission that the Reporting Persons are the beneficial owners thereof for purposes of Section 16 of the Exchange Act or for any other purpose.

Read SEC document
December 11, 2018 Filed Dec 13, 2018 16:02 UTC KERYX BIOPHARMACEUTICALS INC KERX · Entity 161794 GrantCommon Stock 35,582,335 $4.63 $164,746,211.05
Disclosure

SEC source: 0001567619-18-007897 · doc1.xml · nonDerivative · entry 1

BAUPOST GROUP LLC/MA · CIK 0001061768 · Director · 10% owner

Baupost Group GP, L.L.C. · CIK 0001738693 · 10% owner

KLARMAN SETH A · CIK 0000899869 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote 1 and 2

Disclosed balance after: 61,374,013

F1 · ownership.nature: This statement on Form 4 is being jointly filed by The Baupost Group, L.L.C. ("Baupost"), Baupost Group GP, LLC ("Baupost GP") and Seth A. Klarman ("Mr. Klarman") (collectively, the "Reporting Persons"). Baupost is a registered investment adviser. The principal business of Baupost is to act as an investment adviser to various private investment limited partnerships. Baupost GP, as the manager of Baupost, and Mr. Klarman, as the sole managing member of Baupost GP and a controlling person of Baupost, may be deemed to have beneficial ownership under Section 13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), of the securities beneficially owned by Baupost. Securities reported on this Form 4 as being beneficially owned by Baupost were purchased on behalf of certain of such partnerships.

F2 · ownership.nature: (Continued from footnote 1) The Reporting Persons disclaim beneficial ownership of the securities indicated except to the extent of their pecuniary interest therein, and the reporting herein of such securities shall not be construed as an admission that the Reporting Persons are the beneficial owners thereof for purposes of Section 16 of the Exchange Act or for any other purpose.

Read SEC document
October 31, 2018 Filed Oct 31, 2018 16:04 UTC Orexigen Therapeutics, Inc. OREXQ · Entity 157016 SaleCommon Stock 896,339 $0.01 $8,963.39
Disclosure

SEC source: 0001567619-18-004867 · doc1.xml · nonDerivative · entry 2

BAUPOST GROUP LLC/MA · CIK 0001061768 · 10% owner

Baupost Group GP, L.L.C. · CIK 0001738693 · 10% owner

KLARMAN SETH A · CIK 0000899869 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote 1 and 2

Disclosed balance after: 0

F1 · ownership.nature: This statement on Form 4 is being jointly filed by The Baupost Group, L.L.C. ("Baupost"), Baupost Group GP, L.L.C. ("BG GP"), and Seth A. Klarman (collectively, the "Reporting Persons"). Baupost is a registered investment adviser and acts as an investment adviser to various private investment limited partnerships. BG GP, as the Manager of Baupost, and Seth A. Klarman, as the Managing Member of BG GP and a controlling person of Baupost, may be deemed to have beneficial ownership under Section 13 of the Securities Exchange Act of 1934, as amended, of the securities beneficially owned by Baupost. Securities reported on this Form 4 as being beneficially owned by Baupost were purchased on behalf of certain of such partnerships.

F2 · ownership.nature: (Continued from footnote 1) The Reporting Persons disclaim beneficial ownership of the securities indicated except to the extent of their pecuniary therein, and the reporting herein of such securities shall not be construed as an admission that the Reporting Persons are the beneficial owners thereof for purpose of Section 16 or for any other purpose.

Read SEC document
October 29, 2018 Filed Oct 31, 2018 16:04 UTC Orexigen Therapeutics, Inc. OREXQ · Entity 157016 SaleCommon Stock 650,000 $0.01 $6,500.00
Disclosure

SEC source: 0001567619-18-004867 · doc1.xml · nonDerivative · entry 1

BAUPOST GROUP LLC/MA · CIK 0001061768 · 10% owner

Baupost Group GP, L.L.C. · CIK 0001738693 · 10% owner

KLARMAN SETH A · CIK 0000899869 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote 1 and 2

Disclosed balance after: 896,339

F1 · ownership.nature: This statement on Form 4 is being jointly filed by The Baupost Group, L.L.C. ("Baupost"), Baupost Group GP, L.L.C. ("BG GP"), and Seth A. Klarman (collectively, the "Reporting Persons"). Baupost is a registered investment adviser and acts as an investment adviser to various private investment limited partnerships. BG GP, as the Manager of Baupost, and Seth A. Klarman, as the Managing Member of BG GP and a controlling person of Baupost, may be deemed to have beneficial ownership under Section 13 of the Securities Exchange Act of 1934, as amended, of the securities beneficially owned by Baupost. Securities reported on this Form 4 as being beneficially owned by Baupost were purchased on behalf of certain of such partnerships.

F2 · ownership.nature: (Continued from footnote 1) The Reporting Persons disclaim beneficial ownership of the securities indicated except to the extent of their pecuniary therein, and the reporting herein of such securities shall not be construed as an admission that the Reporting Persons are the beneficial owners thereof for purpose of Section 16 or for any other purpose.

Read SEC document
October 25, 2018 Filed Oct 26, 2018 16:12 UTC Orexigen Therapeutics, Inc. OREXQ · Entity 157016 SaleCommon Stock 652,500 $0.01 $6,525.00
Disclosure

SEC source: 0001567619-18-004622 · doc1.xml · nonDerivative · entry 2

BAUPOST GROUP LLC/MA · CIK 0001061768 · 10% owner

Baupost Group GP, L.L.C. · CIK 0001738693 · 10% owner

KLARMAN SETH A · CIK 0000899869 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote 1 and 2

Disclosed balance after: 1,546,339

F1 · ownership.nature: This statement on Form 4 is being jointly filed by The Baupost Group, L.L.C. ("Baupost"), Baupost Group GP, L.L.C. ("BG GP"), and Seth A. Klarman (collectively, the "Reporting Persons"). Baupost is a registered investment adviser and acts as an investment adviser to various private investment limited partnerships. BG GP, as the Manager of Baupost, and Seth A. Klarman, as the Managing Member of BG GP and a controlling person of Baupost, may be deemed to have beneficial ownership under Section 13 of the Securities Exchange Act of 1934, as amended, of the securities beneficially owned by Baupost. Securities reported on this Form 4 as being beneficially owned by Baupost were purchased on behalf of certain of such partnerships.

F2 · ownership.nature: (Continued from footnote 1) The Reporting Persons disclaim beneficial ownership of the securities indicated except to the extent of their pecuniary therein, and the reporting herein of such securities shall not be construed as an admission that the Reporting Persons are the beneficial owners thereof for purpose of Section 16 or for any other purpose.

Read SEC document
October 24, 2018 Filed Oct 26, 2018 16:12 UTC Orexigen Therapeutics, Inc. OREXQ · Entity 157016 SaleCommon Stock 28,000 $0.01 $280.00
Disclosure

SEC source: 0001567619-18-004622 · doc1.xml · nonDerivative · entry 1

BAUPOST GROUP LLC/MA · CIK 0001061768 · 10% owner

Baupost Group GP, L.L.C. · CIK 0001738693 · 10% owner

KLARMAN SETH A · CIK 0000899869 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote 1 and 2

Disclosed balance after: 2,198,839

F1 · ownership.nature: This statement on Form 4 is being jointly filed by The Baupost Group, L.L.C. ("Baupost"), Baupost Group GP, L.L.C. ("BG GP"), and Seth A. Klarman (collectively, the "Reporting Persons"). Baupost is a registered investment adviser and acts as an investment adviser to various private investment limited partnerships. BG GP, as the Manager of Baupost, and Seth A. Klarman, as the Managing Member of BG GP and a controlling person of Baupost, may be deemed to have beneficial ownership under Section 13 of the Securities Exchange Act of 1934, as amended, of the securities beneficially owned by Baupost. Securities reported on this Form 4 as being beneficially owned by Baupost were purchased on behalf of certain of such partnerships.

F2 · ownership.nature: (Continued from footnote 1) The Reporting Persons disclaim beneficial ownership of the securities indicated except to the extent of their pecuniary therein, and the reporting herein of such securities shall not be construed as an admission that the Reporting Persons are the beneficial owners thereof for purpose of Section 16 or for any other purpose.

Read SEC document
May 08, 2018 Filed May 10, 2018 16:31 UTC KERYX BIOPHARMACEUTICALS INC KERX · Entity 161794 GrantZero Coupon Senior Convertible Notes due 2021 · Derivative Not disclosed Not disclosed Strike: $4.63 $164,746,000.00
Disclosure

SEC source: 0001140361-18-022806 · doc1.xml · derivative · entry 2

BAUPOST GROUP LLC/MA · CIK 0001061768 · Director · 10% owner

Baupost Group GP, L.L.C. · CIK 0001738693 · 10% owner

KLARMAN SETH A · CIK 0000899869 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote 1 and 2.

Disclosed balance after: Not disclosed

Underlying: Common Stock · 35,582,335 shares

Expires 2021-10-15

F5 · price: In accordance with the Notes Exchange Agreement, dated as of May 8, 2018, the Baupost Entities agreed to exchange their $125 million principal amount of Zero Coupon Senior Convertible Notes due 2020, plus a cash payment of $10 million, for $164.75 million principal amount of Zero Coupon Senior Convertible Notes due 2021.

F4 · derivative.underlying_shares: Represents the number of shares of common stock of the Issuer underlying the outstanding principal amount of the Zero Coupon Senior Convertible Notes due 2021.

F1 · ownership.nature: This statement on Form 4 is being jointly filed by The Baupost Group, L.L.C. ("Baupost"), Baupost Group GP, LLC ("Baupost GP") and Seth A. Klarman ("Mr. Klarman") (collectively, the "Reporting Persons"). Baupost is a registered investment adviser. The principal business of Baupost is to act as an investment adviser to various private investment limited partnerships. Baupost GP, as the manager of Baupost, and Mr. Klarman, as the sole managing member of Baupost GP and a controlling person of Baupost, may be deemed to have beneficial ownership under Section 13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), of the securities beneficially owned by Baupost. Securities reported on this Form 4 as being beneficially owned by Baupost were purchased on behalf of certain of such partnerships.

F2 · ownership.nature: (Continued from footnote 1) The Reporting Persons disclaim beneficial ownership of the securities indicated except to the extent of their pecuniary interest therein, and the reporting herein of such securities shall not be construed as an admission that the Reporting Persons are the beneficial owners thereof for purposes of Section 16 of the Exchange Act or for any other purpose. Each of the Reporting Persons may be deemed to be a director by deputization of the Issuer for purposes of Section 16(b)-3(d) of the Exchange Act because of the arrangements between Mark Enyedy and the Reporting Persons.

Read SEC document
May 08, 2018 Filed May 10, 2018 16:31 UTC KERYX BIOPHARMACEUTICALS INC KERX · Entity 161794 Disposition to issuerZero Coupon Convertible Senior Notes due 2020 · Derivative Not disclosed $125,000,000.00 Strike: $3.74 $125,000,000.00
Disclosure

SEC source: 0001140361-18-022806 · doc1.xml · derivative · entry 1

BAUPOST GROUP LLC/MA · CIK 0001061768 · Director · 10% owner

Baupost Group GP, L.L.C. · CIK 0001738693 · 10% owner

KLARMAN SETH A · CIK 0000899869 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote 1.

Disclosed balance after: 0

Underlying: Common Stock · 33,422,459 shares

Expires 2020-10-15

F3 · derivative.underlying_shares: Represents the number of shares of common stock of the Issuer underlying the outstanding principal amount of the Zero Coupon Senior Convertible Notes due 2020.

F1 · ownership.nature: This statement on Form 4 is being jointly filed by The Baupost Group, L.L.C. ("Baupost"), Baupost Group GP, LLC ("Baupost GP") and Seth A. Klarman ("Mr. Klarman") (collectively, the "Reporting Persons"). Baupost is a registered investment adviser. The principal business of Baupost is to act as an investment adviser to various private investment limited partnerships. Baupost GP, as the manager of Baupost, and Mr. Klarman, as the sole managing member of Baupost GP and a controlling person of Baupost, may be deemed to have beneficial ownership under Section 13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), of the securities beneficially owned by Baupost. Securities reported on this Form 4 as being beneficially owned by Baupost were purchased on behalf of certain of such partnerships.

F2 · ownership.nature: (Continued from footnote 1) The Reporting Persons disclaim beneficial ownership of the securities indicated except to the extent of their pecuniary interest therein, and the reporting herein of such securities shall not be construed as an admission that the Reporting Persons are the beneficial owners thereof for purposes of Section 16 of the Exchange Act or for any other purpose. Each of the Reporting Persons may be deemed to be a director by deputization of the Issuer for purposes of Section 16(b)-3(d) of the Exchange Act because of the arrangements between Mark Enyedy and the Reporting Persons.

Read SEC document
April 13, 2018 Filed Apr 26, 2018 16:52 UTC Orexigen Therapeutics, Inc. OREX · Entity 157016 Other0% Senior Secured Convertible Notes due 2020 · Derivative 16,483,517 $0.00 Strike: $7.50 $0.00
Disclosure

SEC source: 0001140361-18-019794 · doc1.xml · derivative · entry 1

BAUPOST GROUP LLC/MA · CIK 0001061768 · 10% owner

KLARMAN SETH A · CIK 0000899869 · 10% owner

Baupost Group GP, L.L.C. · CIK 0001738693 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote 1 and 2

Disclosed balance after: 7,802,197

Underlying: Common Stock · 2,197,802 shares

Expires 2020-06-29

F3 · kind: Such aggregate principal amount of the 0% Senior Secured Convertible Notes due 2020 were converted into post-petition secured obligations under a debtor-in-possession credit facility entered into on March 12, 2018, which was subject to a final order approved by the United States Bankruptcy Court for the District of Delaware on April 13, 2018.

F3 · price: Such aggregate principal amount of the 0% Senior Secured Convertible Notes due 2020 were converted into post-petition secured obligations under a debtor-in-possession credit facility entered into on March 12, 2018, which was subject to a final order approved by the United States Bankruptcy Court for the District of Delaware on April 13, 2018.

F4 · balance_after: 7,802,197 shares of common stock are underlying the remaining outstanding aggregate principal amount of the 0% Senior Secured Convertible Notes due 2020. Baupost is not entitled to take delivery of any shares of common stock upon conversion of the reported securities to the extent (but only to the extent) that after such receipt of any shares of common stock upon conversion, Baupost and its affiliates' beneficial ownership would exceed 37.5% of the outstanding shares of the Issuer's common stock.

F1 · ownership.nature: This statement on Form 4 is being jointly filed by The Baupost Group, L.L.C. ("Baupost"), Baupost Group GP, L.L.C. ("BG GP"), and Seth A. Klarman (collectively, the "Reporting Persons"). Baupost is a registered investment adviser and acts as an investment adviser to various private investment limited partnerships. BG GP, as the Manager of Baupost, and Seth A. Klarman, as the Managing Member of BG GP and a controlling person of Baupost, may be deemed to have beneficial ownership under Section 13 of the Securities Exchange Act of 1934, as amended, of the securities beneficially owned by Baupost. Securities reported on this Form 4 as being beneficially owned by Baupost were purchased on behalf of certain of such partnerships.

F2 · ownership.nature: (Continued from footnote 1) The Reporting Persons disclaim beneficial ownership of the securities indicated except to the extent of their pecuniary therein, and the reporting herein of such securities shall not be construed as an admission that the Reporting Persons are the beneficial owners thereof for purpose of Section 16 or for any other purpose.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.